| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.698 | 0.003 | 0.698 | Anesthetic general | 0.679 0.004 DBMET01729 0.679 0.004 DBMET00193 0.62 0.004 DBMET00194 0.609 0.004 DBMET01311 0.241 0.054 DBMET01312 | ||
| 0.698 | 0.008 | 0.866 | Cholesterol antagonist | 0.701 0.008 DBMET01729 0.701 0.008 DBMET00193 0.858 0.003 DBMET00194 0.866 0.003 DBMET01311 0.778 0.004 DBMET01312 | DBMET01311 | |
| 0.7 | 0.031 | 0.836 | Antiinflammatory | 0.731 0.025 DBMET01729 0.731 0.025 DBMET00193 0.829 0.012 DBMET00194 0.836 0.011 DBMET01311 0.721 0.027 DBMET01312 | DBMET01311 | |
| 0.66 | 0.005 | 0.663 | Hypolipemic | 0.663 0.005 DBMET01729 0.663 0.005 DBMET00193 0.582 0.007 DBMET00194 0.573 0.008 DBMET01311 0.458 0.016 DBMET01312 | DBMET00193 | |
| 0.617 | 0.017 | 0.664 | Aldehyde oxidase inhibitor | 0.664 0.011 DBMET01729 0.664 0.011 DBMET00193 | DBMET00193 | |
| 0.581 | 0.013 | 0.77 | Antioxidant | 0.673 0.007 DBMET01729 0.673 0.007 DBMET00193 0.711 0.005 DBMET00194 0.77 0.005 DBMET01311 0.668 0.007 DBMET01312 | DBMET01311 | |
| 0.561 | 0.005 | 0.624 | Peroxidase inhibitor | 0.624 0.004 DBMET01729 0.624 0.004 DBMET00193 0.387 0.022 DBMET01312 | DBMET00193 | |
| 0.546 | 0.017 | 0.656 | Histamine release inhibitor | 0.542 0.018 DBMET01729 0.542 0.018 DBMET00193 0.649 0.007 DBMET00194 0.656 0.006 DBMET01311 0.491 0.032 DBMET01312 | DBMET01311 | |
| 0.523 | 0.005 | 0.569 | Lipid peroxidase inhibitor | 0.569 0.004 DBMET01729 0.569 0.004 DBMET00193 0.394 0.01 DBMET00194 0.461 0.007 DBMET01311 0.45 0.007 DBMET01312 | DBMET00193 | |
| 0.515 | 0.003 | 0.566 | Vanilloid agonist | 0.566 0.003 DBMET01729 0.566 0.003 DBMET00193 0.164 0.009 DBMET00194 0.205 0.006 DBMET01311 0.383 0.004 DBMET01312 | DBMET00193 | |
| 0.532 | 0.022 | 0.532 | 5 Hydroxytryptamine release stimulant | 0.496 0.028 DBMET01729 0.496 0.028 DBMET00193 0.419 0.042 DBMET00194 0.379 0.05 DBMET01311 | ||
| 0.52 | 0.021 | 0.538 | GABA C receptor rho-3 antagonist | 0.538 0.017 DBMET01729 0.538 0.017 DBMET00193 | DBMET00193 | |
| 0.534 | 0.049 | 0.666 | Caspase 9 stimulant | 0.585 0.038 DBMET01729 0.585 0.038 DBMET00193 0.583 0.039 DBMET00194 0.666 0.028 DBMET01311 | DBMET01311 | |
| 0.501 | 0.02 | 0.607 | Apoptosis antagonist | 0.547 0.015 DBMET01729 0.547 0.015 DBMET00193 0.594 0.01 DBMET00194 0.607 0.009 DBMET01311 0.22 0.156 DBMET01312 | DBMET01311 | |
| 0.508 | 0.03 | 0.562 | 5 Hydroxytryptamine release inhibitor | 0.502 0.032 DBMET01729 0.502 0.032 DBMET00193 0.562 0.017 DBMET00194 0.555 0.018 DBMET01311 | DBMET00194 | |
| 0.495 | 0.017 | 0.689 | Free radical scavenger | 0.596 0.009 DBMET01729 0.596 0.009 DBMET00193 0.62 0.007 DBMET00194 0.689 0.005 DBMET01311 0.406 0.028 DBMET01312 | DBMET01311 | |
| 0.474 | 0.003 | 0.524 | TRPA1 agonist | 0.524 0.003 DBMET01729 0.524 0.003 DBMET00193 0.238 0.006 DBMET00194 0.282 0.005 DBMET01311 0.431 0.004 DBMET01312 | DBMET00193 | |
| 0.49 | 0.021 | 0.49 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.475 0.023 DBMET01729 0.475 0.023 DBMET00193 0.149 0.144 DBMET01312 | ||
| 0.531 | 0.065 | 0.691 | Apoptosis agonist | 0.593 0.05 DBMET01729 0.593 0.05 DBMET00193 0.657 0.038 DBMET00194 0.691 0.032 DBMET01311 0.311 0.165 DBMET01312 | DBMET01311 | |
| 0.495 | 0.029 | 0.528 | Vasodilator, peripheral | 0.513 0.025 DBMET01729 0.513 0.025 DBMET00193 0.519 0.024 DBMET00194 0.528 0.023 DBMET01311 | DBMET01311 | |
| 0.469 | 0.016 | 0.624 | Superoxide dismutase inhibitor | 0.493 0.014 DBMET01729 0.493 0.014 DBMET00193 0.624 0.006 DBMET01312 | DBMET01312 | |
| 0.451 | 0.005 | 0.479 | 5-Lipoxygenase inhibitor | 0.479 0.005 DBMET01729 0.479 0.005 DBMET00193 | DBMET00193 | |
| 0.446 | 0.005 | 0.486 | Neurotrophic factor enhancer | 0.486 0.004 DBMET01729 0.486 0.004 DBMET00193 0.408 0.005 DBMET00194 0.475 0.004 DBMET01311 0.197 0.079 DBMET01312 | DBMET00193 | |
| 0.438 | 0.005 | 0.456 | Cyclooxygenase 1 inhibitor | 0.456 0.005 DBMET01729 0.456 0.005 DBMET00193 0.127 0.073 DBMET00194 0.143 0.061 DBMET01311 0.37 0.009 DBMET01312 | DBMET00193 | |
| 0.434 | 0.009 | 0.434 | 5 Hydroxytryptamine uptake stimulant | 0.398 0.014 DBMET01729 0.398 0.014 DBMET00193 0.199 0.154 DBMET01312 | ||
| 0.45 | 0.026 | 0.477 | Lipoxygenase inhibitor | 0.477 0.022 DBMET01729 0.477 0.022 DBMET00193 0.214 0.127 DBMET01312 | DBMET00193 | |
| 0.427 | 0.008 | 0.659 | Alpha-N-acetylglucosaminidase inhibitor | 0.386 0.01 DBMET01729 0.386 0.01 DBMET00193 0.659 0.003 DBMET00194 0.567 0.004 DBMET01311 0.126 0.072 DBMET01312 | DBMET00194 | |
| 0.414 | 0.007 | 0.452 | Tyrosine 3 hydroxylase inhibitor | 0.452 0.005 DBMET01729 0.452 0.005 DBMET00193 0.231 0.089 DBMET01312 | DBMET00193 | |
| 0.409 | 0.011 | 0.643 | Melanin inhibitor | 0.473 0.008 DBMET01729 0.473 0.008 DBMET00193 0.554 0.005 DBMET00194 0.643 0.004 DBMET01311 0.159 0.071 DBMET01312 | DBMET01311 | |
| 0.411 | 0.014 | 0.425 | Sodium/bile acid cotransporter inhibitor | 0.425 0.011 DBMET01729 0.425 0.011 DBMET00193 0.32 0.062 DBMET00194 0.344 0.044 DBMET01311 0.387 0.021 DBMET01312 | DBMET00193 | |
| 0.437 | 0.056 | 0.778 | Transcription factor NF kappa B inhibitor | 0.489 0.046 DBMET01729 0.489 0.046 DBMET00193 0.713 0.019 DBMET00194 0.778 0.014 DBMET01311 0.318 0.086 DBMET01312 | DBMET01311 | |
| 0.385 | 0.006 | 0.392 | Heat shock protein 90 alpha antagonist | 0.392 0.005 DBMET01729 0.392 0.005 DBMET00193 0.126 0.118 DBMET01311 | DBMET00193 | |
| 0.393 | 0.014 | 0.554 | Non-steroidal antiinflammatory agent | 0.375 0.016 DBMET01729 0.375 0.016 DBMET00193 0.554 0.005 DBMET00194 0.541 0.005 DBMET01311 0.204 0.068 DBMET01312 | DBMET00194 | |
| 0.379 | 0.003 | 0.379 | Acetyl-CoA transferase inhibitor | 0.352 0.003 DBMET01729 0.352 0.003 DBMET00193 0.098 0.014 DBMET00194 0.085 0.018 DBMET01311 0.117 0.009 DBMET01312 | ||
| 0.394 | 0.027 | 0.394 | Calcium channel activator | 0.389 0.029 DBMET01729 0.389 0.029 DBMET00193 0.233 0.168 DBMET01312 | ||
| 0.4 | 0.039 | 0.43 | 12-Lipoxygenase inhibitor | 0.43 0.032 DBMET01729 0.43 0.032 DBMET00193 | DBMET00193 | |
| 0.355 | 0.005 | 0.366 | Heat shock protein 90 antagonist | 0.366 0.005 DBMET01729 0.366 0.005 DBMET00193 0.177 0.051 DBMET00194 0.21 0.033 DBMET01311 | DBMET00193 | |
| 0.407 | 0.06 | 0.554 | Immunosuppressant | 0.405 0.06 DBMET01729 0.405 0.06 DBMET00193 0.554 0.02 DBMET00194 0.548 0.021 DBMET01311 0.308 0.11 DBMET01312 | DBMET00194 | |
| 0.347 | 0.002 | 0.39 | Thyroid hormone alpha antagonist | 0.39 0.002 DBMET01729 0.39 0.002 DBMET00193 0.027 0.005 DBMET00194 0.034 0.005 DBMET01311 0.048 0.004 DBMET01312 | DBMET00193 | |
| 0.399 | 0.056 | 0.399 | Thyroid hormone antagonist | 0.391 0.058 DBMET01729 0.391 0.058 DBMET00193 | ||
| 0.414 | 0.072 | 0.414 | Calcium channel L-type activator | 0.402 0.08 DBMET01729 0.402 0.08 DBMET00193 | ||
| 0.355 | 0.013 | 0.712 | Monophenol monooxygenase inhibitor | 0.444 0.01 DBMET01729 0.444 0.01 DBMET00193 0.608 0.005 DBMET00194 0.712 0.004 DBMET01311 0.28 0.02 DBMET01312 | DBMET01311 | |
| 0.355 | 0.014 | 0.454 | Phospholipase C inhibitor | 0.388 0.011 DBMET01729 0.388 0.011 DBMET00193 0.202 0.042 DBMET00194 0.227 0.031 DBMET01311 0.454 0.008 DBMET01312 | DBMET01312 | |
| 0.357 | 0.023 | 0.473 | RNA-directed DNA polymerase inhibitor | 0.377 0.021 DBMET01729 0.377 0.021 DBMET00193 0.384 0.02 DBMET00194 0.41 0.017 DBMET01311 0.473 0.012 DBMET01312 | DBMET01312 | |
| 0.415 | 0.083 | 0.83 | Cyclophilin D inhibitor | 0.452 0.066 DBMET01729 0.452 0.066 DBMET00193 0.83 0.005 DBMET00194 0.829 0.005 DBMET01311 0.485 0.055 DBMET01312 | DBMET00194 | |
| 0.403 | 0.073 | 0.438 | 15-Lipoxygenase inhibitor | 0.438 0.058 DBMET01729 0.438 0.058 DBMET00193 0.364 0.091 DBMET01312 | DBMET00193 | |
| 0.388 | 0.068 | 0.388 | Calpain 2 inhibitor | 0.363 0.08 DBMET01729 0.363 0.08 DBMET00193 | ||
| 0.321 | 0.004 | 0.34 | Vanilloid 1 agonist | 0.34 0.004 DBMET01729 0.34 0.004 DBMET00193 0.242 0.006 DBMET00194 0.272 0.005 DBMET01311 0.255 0.005 DBMET01312 | DBMET00193 | |
| 0.36 | 0.051 | 0.565 | Vasodilator, coronary | 0.375 0.044 DBMET01729 0.375 0.044 DBMET00193 0.549 0.01 DBMET00194 0.565 0.009 DBMET01311 | DBMET01311 | |
| 0.311 | 0.002 | 0.324 | Purinergic P2X2 antagonist | 0.324 0.002 DBMET01729 0.324 0.002 DBMET00193 0.191 0.005 DBMET00194 0.202 0.005 DBMET01311 0.263 0.003 DBMET01312 | DBMET00193 | |
| 0.357 | 0.05 | 0.514 | Spasmolytic | 0.37 0.047 DBMET01729 0.37 0.047 DBMET00193 0.491 0.024 DBMET00194 0.514 0.021 DBMET01311 0.31 0.066 DBMET01312 | DBMET01311 | |
| 0.402 | 0.099 | 0.402 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.345 0.156 DBMET01729 0.345 0.156 DBMET00193 | ||
| 0.362 | 0.065 | 0.362 | Thyroid hormone beta antagonist | 0.351 0.068 DBMET01729 0.351 0.068 DBMET00193 | ||
| 0.355 | 0.06 | 0.355 | Streptokinase A inhibitor | 0.338 0.066 DBMET01729 0.338 0.066 DBMET00193 | ||
| 0.295 | 0.002 | 0.295 | Glycine receptor agonist | 0.279 0.003 DBMET01729 0.279 0.003 DBMET00193 0.235 0.003 DBMET00194 0.229 0.004 DBMET01311 0.189 0.004 DBMET01312 | ||
| 0.311 | 0.018 | 0.514 | Interferon gamma antagonist | 0.334 0.016 DBMET01729 0.334 0.016 DBMET00193 0.492 0.006 DBMET00194 0.514 0.005 DBMET01311 0.137 0.098 DBMET01312 | DBMET01311 | |
| 0.307 | 0.016 | 0.313 | Cyclooxygenase inhibitor | 0.313 0.016 DBMET01729 0.313 0.016 DBMET00193 0.212 0.037 DBMET01312 | DBMET00193 | |
| 0.335 | 0.05 | 0.36 | Hypoxia-inducible factor 1 alpha inhibitor | 0.36 0.042 DBMET01729 0.36 0.042 DBMET00193 0.309 0.062 DBMET00194 0.356 0.043 DBMET01311 | DBMET00193 | |
| 0.294 | 0.015 | 0.294 | Nav1.2 sodium channel blocker | 0.249 0.022 DBMET01729 0.249 0.022 DBMET00193 0.227 0.026 DBMET01312 | ||
| 0.302 | 0.023 | 0.325 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.325 0.017 DBMET01729 0.325 0.017 DBMET00193 0.218 0.059 DBMET00194 0.256 0.04 DBMET01311 | DBMET00193 | |
| 0.287 | 0.013 | 0.287 | Succinate dehydrogenase inhibitor | 0.277 0.015 DBMET01729 0.277 0.015 DBMET00193 0.145 0.123 DBMET00194 0.142 0.129 DBMET01311 0.205 0.045 DBMET01312 | ||
| 0.363 | 0.095 | 0.673 | Antibacterial | 0.388 0.082 DBMET01729 0.388 0.082 DBMET00193 0.657 0.012 DBMET00194 0.673 0.011 DBMET01311 0.529 0.033 DBMET01312 | DBMET01311 | |
| 0.275 | 0.011 | 0.275 | GABA C receptor agonist | 0.275 0.011 DBMET01729 0.275 0.011 DBMET00193 | ||
| 0.277 | 0.016 | 0.325 | NADPH oxidase inhibitor | 0.309 0.011 DBMET01729 0.309 0.011 DBMET00193 0.272 0.016 DBMET00194 0.325 0.009 DBMET01311 | DBMET01311 | |
| 0.296 | 0.036 | 0.296 | Gastrin inhibitor | 0.274 0.054 DBMET01729 0.274 0.054 DBMET00193 0.258 0.07 DBMET00194 0.215 0.126 DBMET01311 | ||
| 0.275 | 0.015 | 0.275 | Anesthetic local | 0.252 0.019 DBMET01729 0.252 0.019 DBMET00193 | ||
| 0.257 | 0.002 | 0.271 | Thyroid hormone alpha agonist | 0.271 0.001 DBMET01729 0.271 0.001 DBMET00193 0.03 0.004 DBMET00194 0.032 0.004 DBMET01311 0.047 0.003 DBMET01312 | DBMET00193 | |
| 0.3 | 0.048 | 0.454 | Interleukin agonist | 0.305 0.046 DBMET01729 0.305 0.046 DBMET00193 0.454 0.012 DBMET00194 0.454 0.012 DBMET01311 | DBMET01311 | |
| 0.315 | 0.064 | 0.484 | Interleukin 2 agonist | 0.34 0.05 DBMET01729 0.34 0.05 DBMET00193 0.477 0.011 DBMET00194 0.484 0.01 DBMET01311 | DBMET01311 | |
| 0.256 | 0.006 | 0.256 | GABA C receptor antagonist | 0.256 0.006 DBMET01729 0.256 0.006 DBMET00193 0.174 0.019 DBMET01312 | ||
| 0.273 | 0.023 | 0.62 | Amylase inhibitor | 0.316 0.016 DBMET01729 0.316 0.016 DBMET00193 0.538 0.005 DBMET00194 0.62 0.004 DBMET01311 | DBMET01311 | |
| 0.253 | 0.003 | 0.281 | GABA B receptor agonist | 0.281 0.003 DBMET01729 0.281 0.003 DBMET00193 0.074 0.058 DBMET01311 0.13 0.005 DBMET01312 | DBMET00193 | |
| 0.301 | 0.052 | 0.436 | Antiamyloidogenic | 0.358 0.037 DBMET01729 0.358 0.037 DBMET00193 0.35 0.039 DBMET00194 0.436 0.023 DBMET01311 0.152 0.145 DBMET01312 | DBMET01311 | |
| 0.255 | 0.007 | 0.255 | Porphobilinogen synthase inhibitor | 0.213 0.011 DBMET01729 0.213 0.011 DBMET00193 0.107 0.033 DBMET01312 | ||
| 0.256 | 0.017 | 0.329 | Cholesterol synthesis inhibitor | 0.278 0.014 DBMET01729 0.278 0.014 DBMET00193 0.155 0.042 DBMET00194 0.175 0.034 DBMET01311 0.329 0.009 DBMET01312 | DBMET01312 | |
| 0.263 | 0.024 | 0.305 | Nitric-oxide synthase stimulant | 0.279 0.017 DBMET01729 0.279 0.017 DBMET00193 0.282 0.016 DBMET00194 0.305 0.01 DBMET01311 | DBMET01311 | |
| 0.249 | 0.013 | 0.441 | UDP-glucose 4-epimerase inhibitor | 0.211 0.017 DBMET01729 0.211 0.017 DBMET00193 0.441 0.004 DBMET00194 0.419 0.005 DBMET01311 | DBMET00194 | |
| 0.241 | 0.008 | 0.241 | Arachidonic acid antagonist | 0.238 0.009 DBMET01729 0.238 0.009 DBMET00193 0.183 0.05 DBMET00194 0.178 0.056 DBMET01311 0.203 0.03 DBMET01312 | ||
| 0.237 | 0.005 | 0.283 | Alcohol oxidase inhibitor | 0.283 0.005 DBMET01729 0.283 0.005 DBMET00193 0.058 0.037 DBMET01311 | DBMET00193 | |
| 0.245 | 0.013 | 0.258 | Mannose-6-phosphate isomerase inhibitor | 0.224 0.019 DBMET01729 0.224 0.019 DBMET00193 0.258 0.01 DBMET00194 0.242 0.014 DBMET01311 | DBMET00194 | |
| 0.287 | 0.057 | 0.703 | Hypoglycemic | 0.355 0.037 DBMET01729 0.355 0.037 DBMET00193 0.688 0.005 DBMET00194 0.703 0.005 DBMET01311 | DBMET01311 | |
| 0.237 | 0.008 | 0.525 | Triose-phosphate isomerase inhibitor | 0.195 0.011 DBMET01729 0.195 0.011 DBMET00193 0.459 0.003 DBMET00194 0.364 0.004 DBMET01311 0.525 0.002 DBMET01312 | DBMET01312 | |
| 0.242 | 0.015 | 0.436 | ATPase inhibitor | 0.249 0.014 DBMET01729 0.249 0.014 DBMET00193 0.42 0.003 DBMET00194 0.436 0.003 DBMET01311 | DBMET01311 | |
| 0.252 | 0.026 | 0.483 | Protein kinase stimulant | 0.286 0.019 DBMET01729 0.286 0.019 DBMET00193 0.442 0.006 DBMET00194 0.483 0.004 DBMET01311 | DBMET01311 | |
| 0.237 | 0.012 | 0.237 | GABA receptor agonist | 0.21 0.016 DBMET01729 0.21 0.016 DBMET00193 | ||
| 0.27 | 0.047 | 0.533 | Nitric oxide antagonist | 0.339 0.033 DBMET01729 0.339 0.033 DBMET00193 0.493 0.016 DBMET00194 0.533 0.014 DBMET01311 0.209 0.064 DBMET01312 | DBMET01311 | |
| 0.225 | 0.007 | 0.237 | Creatine kinase inhibitor | 0.237 0.006 DBMET01729 0.237 0.006 DBMET00193 0.124 0.038 DBMET01312 | DBMET00193 | |
| 0.222 | 0.006 | 0.245 | Prolactin inhibitor | 0.245 0.004 DBMET01729 0.245 0.004 DBMET00193 0.082 0.078 DBMET01312 | DBMET00193 | |
| 0.232 | 0.016 | 0.232 | Ferrochelatase inhibitor | 0.198 0.023 DBMET01729 0.198 0.023 DBMET00193 | ||
| 0.231 | 0.018 | 0.282 | Cystathionine beta-synthase inhibitor | 0.282 0.011 DBMET01729 0.282 0.011 DBMET00193 0.205 0.023 DBMET00194 0.276 0.012 DBMET01311 | DBMET00193 | |
| 0.219 | 0.008 | 0.219 | HIV-1 integrase (Overall Integration) inhibitor | 0.196 0.013 DBMET01729 0.196 0.013 DBMET00193 0.136 0.031 DBMET01312 | ||
| 0.251 | 0.043 | 0.574 | Hepatoprotectant | 0.294 0.031 DBMET01729 0.294 0.031 DBMET00193 0.558 0.005 DBMET00194 0.574 0.005 DBMET01311 0.31 0.027 DBMET01312 | DBMET01311 | |
| 0.206 | 0.003 | 0.206 | Acetyl-CoA transferase 1 inhibitor | 0.177 0.004 DBMET01729 0.177 0.004 DBMET00193 0.045 0.024 DBMET00194 0.038 0.033 DBMET01311 0.054 0.013 DBMET01312 | ||
| 0.219 | 0.017 | 0.274 | Farnesoid X receptor antagonist | 0.274 0.008 DBMET01729 0.274 0.008 DBMET00193 0.13 0.083 DBMET01311 0.146 0.057 DBMET01312 | DBMET00193 | |
| 0.293 | 0.093 | 0.704 | Antithrombotic | 0.3 0.088 DBMET01729 0.3 0.088 DBMET00193 0.699 0.008 DBMET00194 0.704 0.008 DBMET01311 0.53 0.025 DBMET01312 | DBMET01311 | |
| 0.26 | 0.06 | 0.416 | DNA synthesis inhibitor | 0.263 0.059 DBMET01729 0.263 0.059 DBMET00193 0.412 0.02 DBMET00194 0.416 0.02 DBMET01311 0.171 0.167 DBMET01312 | DBMET01311 | |
| 0.209 | 0.01 | 0.221 | Adenylate cyclase stimulant | 0.221 0.007 DBMET01729 0.221 0.007 DBMET00193 0.143 0.076 DBMET00194 0.157 0.053 DBMET01311 0.211 0.009 DBMET01312 | DBMET00193 | |
| 0.236 | 0.038 | 0.236 | Lipocortins synthesis antagonist | 0.213 0.049 DBMET01729 0.213 0.049 DBMET00193 0.193 0.061 DBMET00194 0.171 0.079 DBMET01311 | ||
| 0.27 | 0.074 | 0.27 | Transcription factor STAT inhibitor | 0.268 0.075 DBMET01729 0.268 0.075 DBMET00193 | ||
| 0.256 | 0.061 | 0.405 | Cyclic AMP phosphodiesterase inhibitor | 0.277 0.051 DBMET01729 0.277 0.051 DBMET00193 0.383 0.019 DBMET00194 0.405 0.016 DBMET01311 | DBMET01311 | |
| 0.272 | 0.077 | 0.272 | Insulysin inhibitor | 0.271 0.079 DBMET01729 0.271 0.079 DBMET00193 | ||
| 0.208 | 0.013 | 0.208 | Potassium channel (Ca-activated) activator | 0.174 0.021 DBMET01729 0.174 0.021 DBMET00193 | ||
| 0.197 | 0.004 | 0.206 | Heat shock protein 90 beta antagonist | 0.206 0.004 DBMET01729 0.206 0.004 DBMET00193 | DBMET00193 | |
| 0.219 | 0.031 | 0.234 | Interleukin 6 antagonist | 0.207 0.037 DBMET01729 0.207 0.037 DBMET00193 0.234 0.027 DBMET00194 0.229 0.028 DBMET01311 | DBMET00194 | |
| 0.204 | 0.017 | 0.566 | Cyclooxygenase 3 inhibitor | 0.205 0.017 DBMET01729 0.205 0.017 DBMET00193 0.561 0.003 DBMET00194 0.566 0.003 DBMET01311 | DBMET01311 | |
| 0.204 | 0.018 | 0.226 | Nav1.4 sodium channel blocker | 0.212 0.016 DBMET01729 0.212 0.016 DBMET00193 0.226 0.013 DBMET01312 | DBMET01312 | |
| 0.198 | 0.014 | 0.2 | Mucolytic | 0.2 0.013 DBMET01729 0.2 0.013 DBMET00193 0.191 0.015 DBMET00194 0.198 0.014 DBMET01311 0.116 0.058 DBMET01312 | DBMET00193 | |
| 0.26 | 0.075 | 0.327 | DNA damaging | 0.264 0.073 DBMET01729 0.264 0.073 DBMET00193 0.314 0.052 DBMET00194 0.327 0.048 DBMET01311 | DBMET01311 | |
| 0.253 | 0.068 | 0.828 | Angiogenesis stimulant | 0.304 0.048 DBMET01729 0.304 0.048 DBMET00193 0.818 0.004 DBMET00194 0.828 0.003 DBMET01311 0.628 0.005 DBMET01312 | DBMET01311 | |
| 0.187 | 0.003 | 0.197 | Estrogen-related receptor beta agonist | 0.197 0.003 DBMET01729 0.197 0.003 DBMET00193 0.081 0.064 DBMET00194 0.088 0.044 DBMET01311 0.098 0.027 DBMET01312 | DBMET00193 | |
| 0.249 | 0.066 | 0.249 | Calpain inhibitor | 0.238 0.077 DBMET01729 0.238 0.077 DBMET00193 | ||
| 0.201 | 0.018 | 0.201 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.2 0.018 DBMET01729 0.2 0.018 DBMET00193 | ||
| 0.192 | 0.01 | 0.192 | Sphingosine 1-phosphate receptor 2 antagonist | 0.192 0.01 DBMET01729 0.192 0.01 DBMET00193 0.122 0.093 DBMET01312 | ||
| 0.192 | 0.009 | 0.215 | Keratolytic | 0.215 0.007 DBMET01729 0.215 0.007 DBMET00193 0.07 0.064 DBMET01311 | DBMET00193 | |
| 0.186 | 0.005 | 0.186 | Ca2+-transporting ATPase inhibitor | 0.179 0.008 DBMET01729 0.179 0.008 DBMET00193 0.181 0.007 DBMET00194 0.174 0.01 DBMET01311 0.137 0.083 DBMET01312 | ||
| 0.24 | 0.061 | 0.361 | Amyloid beta aggregation inhibitor | 0.361 0.032 DBMET01729 0.361 0.032 DBMET00193 0.134 0.122 DBMET00194 0.211 0.072 DBMET01311 | DBMET00193 | |
| 0.192 | 0.013 | 0.192 | Pregnane X receptor agonist | 0.183 0.017 DBMET01729 0.183 0.017 DBMET00193 0.151 0.051 DBMET01312 | ||
| 0.256 | 0.079 | 0.256 | Transcription factor STAT3 inhibitor | 0.254 0.08 DBMET01729 0.254 0.08 DBMET00193 | ||
| 0.213 | 0.036 | 0.213 | Phospholipase A2 inhibitor | 0.206 0.039 DBMET01729 0.206 0.039 DBMET00193 0.146 0.079 DBMET00194 0.143 0.083 DBMET01311 0.158 0.067 DBMET01312 | ||
| 0.233 | 0.058 | 0.364 | DNA methylase inhibitor | 0.249 0.049 DBMET01729 0.249 0.049 DBMET00193 0.339 0.019 DBMET00194 0.364 0.015 DBMET01311 | DBMET01311 | |
| 0.191 | 0.017 | 0.279 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.147 0.027 DBMET01729 0.147 0.027 DBMET00193 0.279 0.007 DBMET00194 0.196 0.016 DBMET01311 | DBMET00194 | |
| 0.183 | 0.011 | 0.186 | ABCA1 expression enhancer | 0.186 0.011 DBMET01729 0.186 0.011 DBMET00193 0.091 0.064 DBMET01312 | DBMET00193 | |
| 0.218 | 0.046 | 0.221 | Histone acetyltransferase inhibitor | 0.221 0.043 DBMET01729 0.221 0.043 DBMET00193 | DBMET00193 | |
| 0.198 | 0.03 | 0.345 | Protein-tyrosine phosphatase 1B inhibitor | 0.218 0.024 DBMET01729 0.218 0.024 DBMET00193 0.165 0.04 DBMET00194 0.184 0.034 DBMET01311 0.345 0.008 DBMET01312 | DBMET01312 | |
| 0.198 | 0.03 | 0.203 | GABA C receptor rho-2 antagonist | 0.203 0.027 DBMET01729 0.203 0.027 DBMET00193 | DBMET00193 | |
| 0.19 | 0.023 | 0.501 | Expectorant | 0.195 0.021 DBMET01729 0.195 0.021 DBMET00193 0.481 0.004 DBMET00194 0.501 0.004 DBMET01311 0.091 0.079 DBMET01312 | DBMET01311 | |
| 0.21 | 0.043 | 0.491 | Protein-tyrosine phosphatase inhibitor | 0.23 0.036 DBMET01729 0.23 0.036 DBMET00193 0.159 0.07 DBMET00194 0.177 0.058 DBMET01311 0.491 0.005 DBMET01312 | DBMET01312 | |
| 0.192 | 0.026 | 0.233 | Chelator | 0.233 0.019 DBMET01729 0.233 0.019 DBMET00193 0.092 0.09 DBMET01311 | DBMET00193 | |
| 0.183 | 0.018 | 0.589 | Mediator release inhibitor | 0.196 0.015 DBMET01729 0.196 0.015 DBMET00193 0.533 0.004 DBMET00194 0.589 0.004 DBMET01311 | DBMET01311 | |
| 0.196 | 0.032 | 0.198 | Cyclooxygenase 2 inhibitor | 0.198 0.031 DBMET01729 0.198 0.031 DBMET00193 0.169 0.042 DBMET01312 | DBMET00193 | |
| 0.198 | 0.036 | 0.205 | Neurotensin receptor agonist | 0.205 0.032 DBMET01729 0.205 0.032 DBMET00193 | DBMET00193 | |
| 0.191 | 0.03 | 0.233 | Aldehyde dehydrogenase inhibitor | 0.201 0.027 DBMET01729 0.201 0.027 DBMET00193 0.205 0.027 DBMET00194 0.233 0.021 DBMET01311 | DBMET01311 | |
| 0.173 | 0.013 | 0.173 | GABA A receptor agonist | 0.13 0.02 DBMET01729 0.13 0.02 DBMET00193 | ||
| 0.177 | 0.017 | 0.182 | Papain-like protease (SARS coronavirus) inhibitor | 0.182 0.015 DBMET01729 0.182 0.015 DBMET00193 | DBMET00193 | |
| 0.174 | 0.017 | 0.323 | Estrogen antagonist | 0.323 0.005 DBMET01729 0.323 0.005 DBMET00193 0.124 0.047 DBMET01311 0.119 0.056 DBMET01312 | DBMET00193 | |
| 0.165 | 0.008 | 0.172 | TRPA1 antagonist | 0.172 0.007 DBMET01729 0.172 0.007 DBMET00193 | DBMET00193 | |
| 0.168 | 0.014 | 0.196 | DOPA decarboxylase inhibitor | 0.196 0.007 DBMET01729 0.196 0.007 DBMET00193 | DBMET00193 | |
| 0.162 | 0.008 | 0.187 | Glutamate release inhibitor | 0.141 0.012 DBMET01729 0.141 0.012 DBMET00193 0.187 0.005 DBMET00194 0.157 0.008 DBMET01311 | DBMET00194 | |
| 0.19 | 0.037 | 0.19 | Interleukin 1 antagonist | 0.188 0.038 DBMET01729 0.188 0.038 DBMET00193 | ||
| 0.161 | 0.008 | 0.161 | Ornithine decarboxylase inhibitor | 0.16 0.009 DBMET01729 0.16 0.009 DBMET00193 0.12 0.026 DBMET00194 0.12 0.026 DBMET01311 0.095 0.05 DBMET01312 | ||
| 0.172 | 0.02 | 0.172 | Adenylate kinase inhibitor | 0.158 0.024 DBMET01729 0.158 0.024 DBMET00193 0.139 0.031 DBMET00194 0.117 0.046 DBMET01311 0.108 0.056 DBMET01312 | ||
| 0.2 | 0.049 | 0.203 | Antipruritic | 0.203 0.047 DBMET01729 0.203 0.047 DBMET00193 | DBMET00193 | |
| 0.176 | 0.027 | 0.176 | Sphingosine 1-phosphate receptor 5 antagonist | 0.169 0.035 DBMET01729 0.169 0.035 DBMET00193 | ||
| 0.193 | 0.044 | 0.409 | NOS3 expression enhancer | 0.272 0.022 DBMET01729 0.272 0.022 DBMET00193 0.366 0.01 DBMET00194 0.409 0.008 DBMET01311 | DBMET01311 | |
| 0.204 | 0.056 | 0.204 | 5 Hydroxytryptamine 3E antagonist | 0.187 0.088 DBMET01729 0.187 0.088 DBMET00193 | ||
| 0.202 | 0.054 | 0.233 | Mcl-1 antagonist | 0.233 0.042 DBMET01729 0.233 0.042 DBMET00193 | DBMET00193 | |
| 0.22 | 0.074 | 0.275 | Interleukin antagonist | 0.275 0.054 DBMET01729 0.275 0.054 DBMET00193 | DBMET00193 | |
| 0.157 | 0.011 | 0.175 | Phenylalanine 4-hydroxylase inhibitor | 0.175 0.009 DBMET01729 0.175 0.009 DBMET00193 0.075 0.041 DBMET01312 | DBMET00193 | |
| 0.188 | 0.043 | 0.347 | Hexokinase inhibitor | 0.189 0.042 DBMET01729 0.189 0.042 DBMET00193 0.341 0.007 DBMET00194 0.347 0.006 DBMET01311 | DBMET01311 | |
| 0.155 | 0.012 | 0.277 | CDC25A inhibitor | 0.154 0.012 DBMET01729 0.154 0.012 DBMET00193 0.066 0.064 DBMET00194 0.07 0.057 DBMET01311 0.277 0.004 DBMET01312 | DBMET01312 | |
| 0.208 | 0.065 | 0.209 | Insulin sensitizer | 0.209 0.064 DBMET01729 0.209 0.064 DBMET00193 0.183 0.091 DBMET00194 0.185 0.09 DBMET01311 0.149 0.134 DBMET01312 | DBMET00193 | |
| 0.157 | 0.016 | 0.31 | NADH dehydrogenase inhibitor | 0.148 0.018 DBMET01729 0.148 0.018 DBMET00193 0.31 0.006 DBMET00194 0.288 0.007 DBMET01311 0.1 0.043 DBMET01312 | DBMET00194 | |
| 0.155 | 0.014 | 0.331 | Estrogen receptor beta antagonist | 0.331 0.005 DBMET01729 0.331 0.005 DBMET00193 0.115 0.039 DBMET01312 | DBMET00193 | |
| 0.238 | 0.101 | 0.57 | Immunostimulant | 0.268 0.089 DBMET01729 0.268 0.089 DBMET00193 0.545 0.023 DBMET00194 0.57 0.02 DBMET01311 0.358 0.062 DBMET01312 | DBMET01311 | |
| 0.154 | 0.018 | 0.165 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.165 0.015 DBMET01729 0.165 0.015 DBMET00193 | DBMET00193 | |
| 0.213 | 0.077 | 0.213 | ErbB-1 antagonist | 0.196 0.094 DBMET01729 0.196 0.094 DBMET00193 | ||
| 0.16 | 0.026 | 0.246 | Photosensitizer | 0.162 0.024 DBMET01729 0.162 0.024 DBMET00193 0.24 0.007 DBMET00194 0.246 0.006 DBMET01311 | DBMET01311 | |
| 0.162 | 0.032 | 0.211 | Microtubule formation inhibitor | 0.159 0.033 DBMET01729 0.159 0.033 DBMET00193 0.211 0.017 DBMET00194 0.198 0.02 DBMET01311 | DBMET00194 | |
| 0.162 | 0.033 | 0.183 | Aminopeptidase B inhibitor | 0.15 0.038 DBMET01729 0.15 0.038 DBMET00193 0.183 0.026 DBMET01312 | DBMET01312 | |
| 0.159 | 0.029 | 0.177 | Heat shock protein 70 antagonist | 0.16 0.028 DBMET01729 0.16 0.028 DBMET00193 0.172 0.016 DBMET00194 0.177 0.013 DBMET01311 | DBMET01311 | |
| 0.218 | 0.091 | 0.218 | Neuropeptide Y2 antagonist | 0.211 0.1 DBMET01729 0.211 0.1 DBMET00193 | ||
| 0.168 | 0.041 | 0.188 | Toll-Like receptor 2 antagonist | 0.188 0.03 DBMET01729 0.188 0.03 DBMET00193 | DBMET00193 | |
| 0.186 | 0.06 | 0.186 | 3C-like protease (Human coronavirus) inhibitor | 0.175 0.07 DBMET01729 0.175 0.07 DBMET00193 | ||
| 0.141 | 0.015 | 0.174 | Glutamate decarboxylase inhibitor | 0.174 0.009 DBMET01729 0.174 0.009 DBMET00193 0.084 0.041 DBMET01312 | DBMET00193 | |
| 0.179 | 0.054 | 0.554 | Diuretic | 0.169 0.062 DBMET01729 0.169 0.062 DBMET00193 0.293 0.024 DBMET00194 0.269 0.028 DBMET01311 0.554 0.005 DBMET01312 | DBMET01312 | |
| 0.14 | 0.015 | 0.14 | Lanosterol 14 alpha demethylase inhibitor | 0.129 0.023 DBMET01729 0.129 0.023 DBMET00193 | ||
| 0.145 | 0.021 | 0.167 | Anabolic | 0.154 0.016 DBMET01729 0.154 0.016 DBMET00193 0.089 0.08 DBMET00194 0.1 0.062 DBMET01311 0.167 0.011 DBMET01312 | DBMET01312 | |
| 0.136 | 0.013 | 0.136 | Potassium channel large-conductance Ca-activated activator | 0.099 0.024 DBMET01729 0.099 0.024 DBMET00193 | ||
| 0.126 | 0.004 | 0.18 | Adenine nucleotide translocase inhibitor | 0.121 0.004 DBMET01729 0.121 0.004 DBMET00193 0.076 0.011 DBMET00194 0.078 0.01 DBMET01311 0.18 0.003 DBMET01312 | DBMET01312 | |
| 0.169 | 0.047 | 0.18 | CF transmembrane conductance regulator agonist | 0.18 0.036 DBMET01729 0.18 0.036 DBMET00193 0.135 0.107 DBMET01311 | DBMET00193 | |
| 0.134 | 0.012 | 0.139 | Leukotriene synthesis inhibitor | 0.139 0.011 DBMET01729 0.139 0.011 DBMET00193 | DBMET00193 | |
| 0.139 | 0.02 | 0.253 | Phosphofructokinase-1 inhibitor | 0.133 0.022 DBMET01729 0.133 0.022 DBMET00193 0.253 0.007 DBMET00194 0.246 0.008 DBMET01311 0.072 0.046 DBMET01312 | DBMET00194 | |
| 0.122 | 0.004 | 0.122 | Heme oxygenase stimulant | 0.12 0.004 DBMET01729 0.12 0.004 DBMET00193 0.073 0.021 DBMET00194 0.072 0.023 DBMET01311 0.082 0.014 DBMET01312 | ||
| 0.128 | 0.011 | 0.128 | Granulocyte macrophage colony stimulating factor agonist | 0.113 0.021 DBMET01729 0.113 0.021 DBMET00193 | ||
| 0.119 | 0.004 | 0.119 | Retinoid X alpha receptor agonist | 0.104 0.005 DBMET01729 0.104 0.005 DBMET00193 | ||
| 0.129 | 0.016 | 0.159 | Estrogen receptor alpha antagonist | 0.159 0.011 DBMET01729 0.159 0.011 DBMET00193 0.072 0.063 DBMET01312 | DBMET00193 | |
| 0.195 | 0.084 | 0.201 | Pyruvate kinase inhibitor | 0.201 0.08 DBMET01729 0.201 0.08 DBMET00193 | DBMET00193 | |
| 0.14 | 0.03 | 0.402 | Beta glucuronidase inhibitor | 0.152 0.024 DBMET01729 0.152 0.024 DBMET00193 0.325 0.005 DBMET00194 0.402 0.004 DBMET01311 | DBMET01311 | |
| 0.137 | 0.028 | 0.141 | GABA C receptor rho-1 antagonist | 0.141 0.026 DBMET01729 0.141 0.026 DBMET00193 | DBMET00193 | |
| 0.118 | 0.009 | 0.118 | CC chemokine 5 receptor agonist | 0.113 0.011 DBMET01729 0.113 0.011 DBMET00193 0.104 0.017 DBMET01312 | ||
| 0.136 | 0.027 | 0.154 | Androgen antagonist | 0.154 0.022 DBMET01729 0.154 0.022 DBMET00193 | DBMET00193 | |
| 0.128 | 0.02 | 0.128 | Glutamate dehydrogenase inhibitor | 0.112 0.025 DBMET01729 0.112 0.025 DBMET00193 0.09 0.036 DBMET00194 0.077 0.047 DBMET01311 0.069 0.058 DBMET01312 | ||
| 0.112 | 0.004 | 0.112 | Alpha 1L adrenoreceptor antagonist | 0.11 0.004 DBMET01729 0.11 0.004 DBMET00193 0.053 0.034 DBMET01312 | ||
| 0.125 | 0.017 | 0.125 | 3C-Like protease (SARS coronavirus) inhibitor | 0.118 0.02 DBMET01729 0.118 0.02 DBMET00193 | ||
| 0.111 | 0.004 | 0.132 | Dopamine D5 agonist | 0.132 0.003 DBMET01729 0.132 0.003 DBMET00193 0.037 0.033 DBMET01312 | DBMET00193 | |
| 0.234 | 0.127 | 0.313 | Caspase 3 stimulant | 0.274 0.094 DBMET01729 0.274 0.094 DBMET00193 0.276 0.092 DBMET00194 0.313 0.073 DBMET01311 | DBMET01311 | |
| 0.148 | 0.042 | 0.182 | Beta amyloid protein antagonist | 0.167 0.03 DBMET01729 0.167 0.03 DBMET00193 0.167 0.03 DBMET00194 0.182 0.023 DBMET01311 | DBMET01311 | |
| 0.12 | 0.014 | 0.12 | D-Ala-D-Ala ligase inhibitor | 0.11 0.019 DBMET01729 0.11 0.019 DBMET00193 | ||
| 0.114 | 0.008 | 0.134 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.134 0.006 DBMET01729 0.134 0.006 DBMET00193 0.09 0.013 DBMET01312 | DBMET00193 | |
| 0.123 | 0.018 | 0.13 | Bile acid receptor antagonist | 0.127 0.014 DBMET01729 0.127 0.014 DBMET00193 0.093 0.066 DBMET01311 0.13 0.013 DBMET01312 | DBMET01312 | |
| 0.143 | 0.039 | 0.143 | Interleukin 8 antagonist | 0.14 0.041 DBMET01729 0.14 0.041 DBMET00193 | ||
| 0.143 | 0.04 | 0.143 | Sphingosine 1-phosphate receptor 4 antagonist | 0.134 0.051 DBMET01729 0.134 0.051 DBMET00193 | ||
| 0.255 | 0.152 | 0.486 | Antiobesity | 0.241 0.165 DBMET01729 0.241 0.165 DBMET00193 0.357 0.084 DBMET00194 0.33 0.098 DBMET01311 0.486 0.041 DBMET01312 | DBMET01312 | |
| 0.118 | 0.017 | 0.123 | GABA aminotransferase inhibitor | 0.123 0.015 DBMET01729 0.123 0.015 DBMET00193 0.11 0.021 DBMET00194 0.118 0.017 DBMET01311 | DBMET00193 | |
| 0.12 | 0.02 | 0.12 | Aminopeptidase I inhibitor | 0.112 0.022 DBMET01729 0.112 0.022 DBMET00193 | ||
| 0.112 | 0.013 | 0.112 | Purinergic P2X1 antagonist | 0.095 0.018 DBMET01729 0.095 0.018 DBMET00193 0.056 0.049 DBMET00194 0.058 0.047 DBMET01312 | ||
| 0.178 | 0.081 | 0.305 | DNA methyltransferase I inhibitor | 0.207 0.065 DBMET01729 0.207 0.065 DBMET00193 0.278 0.035 DBMET00194 0.305 0.024 DBMET01311 | DBMET01311 | |
| 0.174 | 0.077 | 0.197 | Amyloid beta precursor protein antagonist | 0.197 0.059 DBMET01729 0.197 0.059 DBMET00193 | DBMET00193 | |
| 0.113 | 0.016 | 0.113 | Argininosuccinate synthase inhibitor | 0.094 0.021 DBMET01729 0.094 0.021 DBMET00193 0.078 0.026 DBMET00194 0.056 0.04 DBMET01311 | ||
| 0.101 | 0.005 | 0.101 | Retinoid X receptor agonist | 0.089 0.006 DBMET01729 0.089 0.006 DBMET00193 | ||
| 0.128 | 0.031 | 0.181 | Catalase inhibitor | 0.139 0.029 DBMET01729 0.139 0.029 DBMET00193 0.181 0.019 DBMET01312 | DBMET01312 | |
| 0.117 | 0.02 | 0.161 | Glycine receptor antagonist | 0.102 0.031 DBMET01729 0.102 0.031 DBMET00193 0.161 0.005 DBMET00194 0.142 0.009 DBMET01311 0.155 0.006 DBMET01312 | DBMET00194 | |
| 0.131 | 0.035 | 0.137 | Urease inhibitor | 0.137 0.031 DBMET01729 0.137 0.031 DBMET00193 | DBMET00193 | |
| 0.1 | 0.005 | 0.1 | Calcium channel P-type blocker | 0.094 0.007 DBMET01729 0.094 0.007 DBMET00193 | ||
| 0.122 | 0.028 | 0.122 | Toll-Like receptor 3 antagonist | 0.086 0.077 DBMET01729 0.086 0.077 DBMET00193 | ||
| 0.118 | 0.024 | 0.118 | Glutathione S-transferase inhibitor | 0.115 0.026 DBMET01729 0.115 0.026 DBMET00193 | ||
| 0.119 | 0.026 | 0.16 | Histidine decarboxylase inhibitor | 0.16 0.018 DBMET01729 0.16 0.018 DBMET00193 | DBMET00193 | |
| 0.116 | 0.023 | 0.144 | ATPase (Vacuolar H+) inhibitor | 0.117 0.022 DBMET01729 0.117 0.022 DBMET00193 0.144 0.009 DBMET00194 0.144 0.009 DBMET01311 | DBMET01311 | |
| 0.143 | 0.05 | 0.305 | Alkylator | 0.158 0.043 DBMET01729 0.158 0.043 DBMET00193 0.263 0.015 DBMET00194 0.305 0.012 DBMET01311 0.128 0.061 DBMET01312 | DBMET01311 | |
| 0.107 | 0.016 | 0.453 | Estrogen agonist | 0.262 0.006 DBMET01729 0.262 0.006 DBMET00193 0.067 0.027 DBMET00194 0.132 0.013 DBMET01311 0.453 0.004 DBMET01312 | DBMET01312 | |
| 0.094 | 0.003 | 0.185 | Thyroid hormone agonist | 0.125 0.002 DBMET01729 0.125 0.002 DBMET00193 0.027 0.017 DBMET00194 0.037 0.007 DBMET01311 0.185 0.002 DBMET01312 | DBMET01312 | |
| 0.107 | 0.016 | 0.107 | Biliverdin reductase inhibitor | 0.092 0.021 DBMET01729 0.092 0.021 DBMET00193 0.073 0.03 DBMET00194 0.054 0.048 DBMET01311 | ||
| 0.095 | 0.004 | 0.095 | Geranyltranstransferase inhibitor | 0.087 0.004 DBMET01729 0.087 0.004 DBMET00193 | ||
| 0.099 | 0.009 | 0.099 | Aconitate hydratase inhibitor | 0.08 0.014 DBMET01729 0.08 0.014 DBMET00193 | ||
| 0.095 | 0.005 | 0.095 | Cholesterol esterase inhibitor | 0.081 0.007 DBMET01729 0.081 0.007 DBMET00193 | ||
| 0.195 | 0.105 | 0.197 | Aryl hydrocarbon receptor agonist | 0.197 0.104 DBMET01729 0.197 0.104 DBMET00193 | DBMET00193 | |
| 0.132 | 0.041 | 0.132 | Nav1.1 sodium channel blocker | 0.121 0.047 DBMET01729 0.121 0.047 DBMET00193 | ||
| 0.132 | 0.042 | 0.132 | Transcription factor STAT6 inhibitor | 0.126 0.05 DBMET01729 0.126 0.05 DBMET00193 | ||
| 0.117 | 0.027 | 0.141 | Macrophage migration inhibitory factor inhibitor | 0.141 0.018 DBMET01729 0.141 0.018 DBMET00193 | DBMET00193 | |
| 0.152 | 0.064 | 0.395 | Cell wall synthesis inhibitor | 0.161 0.055 DBMET01729 0.161 0.055 DBMET00193 0.379 0.007 DBMET00194 0.395 0.006 DBMET01311 0.299 0.01 DBMET01312 | DBMET01311 | |
| 0.128 | 0.041 | 0.144 | Carbonic anhydrase XV inhibitor | 0.144 0.033 DBMET01729 0.144 0.033 DBMET00193 0.091 0.081 DBMET01312 | DBMET00193 | |
| 0.126 | 0.04 | 0.149 | Carbonic anhydrase III inhibitor | 0.146 0.03 DBMET01729 0.146 0.03 DBMET00193 0.085 0.082 DBMET00194 0.109 0.053 DBMET01311 0.149 0.029 DBMET01312 | DBMET01312 | |
| 0.095 | 0.009 | 0.095 | Potassium channel Kv1.3 blocker | 0.073 0.014 DBMET01729 0.073 0.014 DBMET00193 | ||
| 0.102 | 0.017 | 0.102 | Bombesin 1 receptor agonist | 0.095 0.019 DBMET01729 0.095 0.019 DBMET00193 | ||
| 0.094 | 0.009 | 0.096 | Sphingosine kinase 2 inhibitor | 0.096 0.009 DBMET01729 0.096 0.009 DBMET00193 | DBMET00193 | |
| 0.125 | 0.041 | 0.136 | Electron transport complex I inhibitor | 0.136 0.03 DBMET01729 0.136 0.03 DBMET00193 | DBMET00193 | |
| 0.12 | 0.036 | 0.12 | Electrolyte absorption antagonist | 0.097 0.062 DBMET01729 0.097 0.062 DBMET00193 | ||
| 0.099 | 0.016 | 0.101 | CDC25B inhibitor | 0.101 0.015 DBMET01729 0.101 0.015 DBMET00193 | DBMET00193 | |
| 0.107 | 0.024 | 0.107 | Prostaglandin-E synthase inhibitor | 0.096 0.029 DBMET01729 0.096 0.029 DBMET00193 | ||
| 0.089 | 0.007 | 0.089 | Dihydroorotate oxidase inhibitor | 0.088 0.008 DBMET01729 0.088 0.008 DBMET00193 0.051 0.047 DBMET01312 | ||
| 0.097 | 0.017 | 0.097 | Peroxisome proliferator-activated receptor gamma antagonist | 0.095 0.019 DBMET01729 0.095 0.019 DBMET00193 | ||
| 0.135 | 0.055 | 0.135 | Proteasome inhibitor | 0.134 0.056 DBMET01729 0.134 0.056 DBMET00193 | ||
| 0.135 | 0.056 | 0.135 | Adenylate cyclase inhibitor | 0.133 0.057 DBMET01729 0.133 0.057 DBMET00193 | ||
| 0.084 | 0.005 | 0.084 | Pregnane X receptor antagonist | 0.081 0.006 DBMET01729 0.081 0.006 DBMET00193 | ||
| 0.095 | 0.017 | 0.099 | Androgen agonist | 0.099 0.015 DBMET01729 0.099 0.015 DBMET00193 0.087 0.02 DBMET01312 | DBMET00193 | |
| 0.1 | 0.023 | 0.41 | HIV-1 integrase (Strand Transfer) inhibitor | 0.127 0.015 DBMET01729 0.127 0.015 DBMET00193 0.072 0.035 DBMET01311 0.41 0.004 DBMET01312 | DBMET01312 | |
| 0.092 | 0.015 | 0.092 | Glutamate (mGluR6) antagonist | 0.082 0.022 DBMET01729 0.082 0.022 DBMET00193 | ||
| 0.116 | 0.039 | 0.116 | Interleukin 1 beta converting enzyme inhibitor | 0.109 0.046 DBMET01729 0.109 0.046 DBMET00193 | ||
| 0.094 | 0.018 | 0.094 | Acyl-CoA dehydrogenase inhibitor | 0.086 0.02 DBMET01729 0.086 0.02 DBMET00193 0.049 0.043 DBMET00194 | ||
| 0.08 | 0.004 | 0.08 | Alpha 1L adrenoreceptor agonist | 0.08 0.004 DBMET01729 0.08 0.004 DBMET00193 0.05 0.016 DBMET01312 | ||
| 0.141 | 0.066 | 0.166 | Bone formation stimulant | 0.166 0.048 DBMET01729 0.166 0.048 DBMET00193 | DBMET00193 | |
| 0.109 | 0.034 | 0.142 | Carbonic anhydrase VI inhibitor | 0.138 0.024 DBMET01729 0.138 0.024 DBMET00193 0.072 0.069 DBMET01311 0.142 0.023 DBMET01312 | DBMET01312 | |
| 0.115 | 0.041 | 0.196 | Uric acid excretion stimulant | 0.123 0.036 DBMET01729 0.123 0.036 DBMET00193 0.183 0.015 DBMET00194 0.196 0.014 DBMET01311 | DBMET01311 | |
| 0.082 | 0.008 | 0.084 | Ryanodine receptor antagonist | 0.084 0.007 DBMET01729 0.084 0.007 DBMET00193 | DBMET00193 | |
| 0.14 | 0.067 | 0.145 | Nav1.6 sodium channel blocker | 0.145 0.06 DBMET01729 0.145 0.06 DBMET00193 | DBMET00193 | |
| 0.133 | 0.06 | 0.133 | Cathepsin H inhibitor | 0.113 0.085 DBMET01729 0.113 0.085 DBMET00193 | ||
| 0.171 | 0.098 | 0.173 | I kappa B kinase epsilon inhibitor | 0.173 0.097 DBMET01729 0.173 0.097 DBMET00193 | DBMET00193 | |
| 0.09 | 0.017 | 0.09 | Glutamate (mGluR7) antagonist | 0.082 0.025 DBMET01729 0.082 0.025 DBMET00193 | ||
| 0.102 | 0.03 | 0.13 | Na+ K+ transporting ATPase inhibitor | 0.107 0.026 DBMET01729 0.107 0.026 DBMET00193 0.127 0.013 DBMET00194 0.13 0.011 DBMET01311 0.113 0.021 DBMET01312 | DBMET01311 | |
| 0.093 | 0.023 | 0.093 | Carbamoyl phosphate synthetase inhibitor | 0.093 0.023 DBMET01729 0.093 0.023 DBMET00193 0.056 0.048 DBMET01312 | ||
| 0.095 | 0.024 | 0.095 | Leukotriene antagonist | 0.09 0.026 DBMET01729 0.09 0.026 DBMET00193 0.063 0.048 DBMET00194 0.063 0.047 DBMET01311 0.079 0.033 DBMET01312 | ||
| 0.097 | 0.027 | 0.462 | HIV-1 integrase (3'-Processing) inhibitor | 0.131 0.017 DBMET01729 0.131 0.017 DBMET00193 0.073 0.037 DBMET01311 0.462 0.004 DBMET01312 | DBMET01312 | |
| 0.088 | 0.019 | 0.088 | GABA receptor antagonist | 0.073 0.024 DBMET01729 0.073 0.024 DBMET00193 0.054 0.038 DBMET01312 | ||
| 0.091 | 0.023 | 0.094 | MAP kinase kinase 7 inhibitor | 0.094 0.019 DBMET01729 0.094 0.019 DBMET00193 | DBMET00193 | |
| 0.098 | 0.03 | 0.114 | Interferon agonist | 0.085 0.044 DBMET01729 0.085 0.044 DBMET00193 0.114 0.02 DBMET00194 0.093 0.036 DBMET01311 0.081 0.05 DBMET01312 | DBMET00194 | |
| 0.073 | 0.005 | 0.073 | Purinergic P2X3 antagonist | 0.069 0.006 DBMET01729 0.069 0.006 DBMET00193 | ||
| 0.086 | 0.018 | 0.101 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.081 0.02 DBMET01729 0.081 0.02 DBMET00193 0.101 0.014 DBMET00194 0.085 0.018 DBMET01311 | DBMET00194 | |
| 0.078 | 0.011 | 0.078 | Acetyl-CoA transferase 2 inhibitor | 0.075 0.013 DBMET01729 0.075 0.013 DBMET00193 | ||
| 0.1 | 0.033 | 0.1 | mTOR complex 2 inhibitor | 0.094 0.041 DBMET01729 0.094 0.041 DBMET00193 | ||
| 0.069 | 0.004 | 0.069 | Retinoid X receptor antagonist | 0.063 0.005 DBMET01729 0.063 0.005 DBMET00193 | ||
| 0.122 | 0.057 | 0.122 | Caspase 3 inhibitor | 0.11 0.075 DBMET01729 0.11 0.075 DBMET00193 | ||
| 0.078 | 0.013 | 0.341 | Leukocyte elastase inhibitor | 0.072 0.014 DBMET01729 0.072 0.014 DBMET00193 0.341 0.003 DBMET01312 | DBMET01312 | |
| 0.088 | 0.024 | 0.088 | Phospholipase D inhibitor | 0.078 0.037 DBMET01729 0.078 0.037 DBMET00193 0.087 0.026 DBMET01312 | ||
| 0.107 | 0.043 | 0.107 | Calcium antagonist | 0.092 0.053 DBMET01729 0.092 0.053 DBMET00193 | ||
| 0.086 | 0.022 | 0.086 | Maillard reaction inhibitor | 0.085 0.023 DBMET01729 0.085 0.023 DBMET00193 | ||
| 0.086 | 0.022 | 0.107 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.101 0.017 DBMET01729 0.101 0.017 DBMET00193 0.082 0.024 DBMET00194 0.107 0.015 DBMET01311 | DBMET01311 | |
| 0.068 | 0.005 | 0.068 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.067 0.005 DBMET01729 0.067 0.005 DBMET00193 0.047 0.018 DBMET01312 | ||
| 0.074 | 0.01 | 0.074 | CXC chemokine 1 receptor antagonist | 0.068 0.014 DBMET01729 0.068 0.014 DBMET00193 0.051 0.035 DBMET01312 | ||
| 0.083 | 0.02 | 0.083 | GABA A receptor antagonist | 0.069 0.026 DBMET01729 0.069 0.026 DBMET00193 | ||
| 0.108 | 0.045 | 0.108 | Glutamate (mGluR7) agonist | 0.099 0.061 DBMET01729 0.099 0.061 DBMET00193 | ||
| 0.182 | 0.12 | 0.389 | Vasodilator | 0.231 0.082 DBMET01729 0.231 0.082 DBMET00193 0.364 0.03 DBMET00194 0.389 0.025 DBMET01311 | DBMET01311 | |
| 0.106 | 0.044 | 0.154 | Interleukin 12 antagonist | 0.129 0.022 DBMET01729 0.129 0.022 DBMET00193 0.14 0.016 DBMET00194 0.154 0.011 DBMET01311 | DBMET01311 | |
| 0.132 | 0.07 | 0.137 | Toll-Like receptor antagonist | 0.137 0.065 DBMET01729 0.137 0.065 DBMET00193 | DBMET00193 | |
| 0.083 | 0.021 | 0.095 | Interferon inducer | 0.072 0.032 DBMET01729 0.072 0.032 DBMET00193 0.095 0.015 DBMET00194 0.078 0.026 DBMET01311 0.071 0.034 DBMET01312 | DBMET00194 | |
| 0.11 | 0.049 | 0.115 | Folate antagonist | 0.112 0.046 DBMET01729 0.112 0.046 DBMET00193 0.115 0.044 DBMET00194 0.112 0.047 DBMET01311 | DBMET00194 | |
| 0.072 | 0.012 | 0.109 | Glucose-6-phosphate isomerase inhibitor | 0.07 0.012 DBMET01729 0.07 0.012 DBMET00193 0.109 0.004 DBMET00194 0.099 0.005 DBMET01311 0.05 0.03 DBMET01312 | DBMET00194 | |
| 0.078 | 0.018 | 0.078 | Sphingosine 1-phosphate receptor 3 antagonist | 0.076 0.02 DBMET01729 0.076 0.02 DBMET00193 | ||
| 0.067 | 0.008 | 0.073 | Alpha 1d adrenoreceptor agonist | 0.073 0.006 DBMET01729 0.073 0.006 DBMET00193 | DBMET00193 | |
| 0.077 | 0.019 | 0.077 | Botulinum neurotoxin type A inhibitor | 0.068 0.027 DBMET01729 0.068 0.027 DBMET00193 | ||
| 0.094 | 0.036 | 0.236 | Cathepsin G inhibitor | 0.082 0.042 DBMET01729 0.082 0.042 DBMET00193 0.236 0.013 DBMET01312 | DBMET01312 | |
| 0.087 | 0.03 | 0.087 | Vanilloid 4 agonist | 0.08 0.041 DBMET01729 0.08 0.041 DBMET00193 | ||
| 0.068 | 0.011 | 0.068 | Urate transporter 1 inhibitor | 0.061 0.014 DBMET01729 0.061 0.014 DBMET00193 | ||
| 0.077 | 0.021 | 0.077 | Cyclin D1 inhibitor | 0.075 0.022 DBMET01729 0.075 0.022 DBMET00193 | ||
| 0.07 | 0.014 | 0.075 | Squalene epoxidase inhibitor | 0.075 0.012 DBMET01729 0.075 0.012 DBMET00193 | DBMET00193 | |
| 0.065 | 0.01 | 0.069 | Liver X receptor alpha agonist | 0.069 0.009 DBMET01729 0.069 0.009 DBMET00193 | DBMET00193 | |
| 0.08 | 0.025 | 0.08 | NMDA 2C receptor antagonist | 0.078 0.026 DBMET01729 0.078 0.026 DBMET00193 0.074 0.029 DBMET01312 | ||
| 0.079 | 0.024 | 0.083 | Beta 3 adrenoreceptor antagonist | 0.083 0.021 DBMET01729 0.083 0.021 DBMET00193 | DBMET00193 | |
| 0.059 | 0.004 | 0.059 | Retinoid X alpha receptor antagonist | 0.053 0.005 DBMET01729 0.053 0.005 DBMET00193 | ||
| 0.089 | 0.035 | 0.095 | Lipase inhibitor | 0.095 0.03 DBMET01729 0.095 0.03 DBMET00193 | DBMET00193 | |
| 0.13 | 0.076 | 0.203 | Alkaline phosphatase inhibitor | 0.147 0.062 DBMET01729 0.147 0.062 DBMET00193 0.136 0.07 DBMET00194 0.166 0.05 DBMET01311 0.203 0.032 DBMET01312 | DBMET01312 | |
| 0.121 | 0.067 | 0.198 | DNA polymerase I inhibitor | 0.158 0.045 DBMET01729 0.158 0.045 DBMET00193 0.177 0.036 DBMET00194 0.198 0.029 DBMET01311 | DBMET01311 | |
| 0.152 | 0.098 | 0.16 | Tumour necrosis factor antagonist | 0.16 0.088 DBMET01729 0.16 0.088 DBMET00193 | DBMET00193 | |
| 0.074 | 0.02 | 0.111 | Sphingosine kinase inhibitor | 0.077 0.019 DBMET01729 0.077 0.019 DBMET00193 0.111 0.005 DBMET01312 | DBMET01312 | |
| 0.094 | 0.041 | 0.103 | Adrenaline agonist | 0.103 0.035 DBMET01729 0.103 0.035 DBMET00193 | DBMET00193 | |
| 0.077 | 0.024 | 0.077 | MDM2 inhibitor | 0.074 0.03 DBMET01729 0.074 0.03 DBMET00193 | ||
| 0.057 | 0.005 | 0.057 | HMG CoA reductase inhibitor | 0.057 0.005 DBMET01729 0.057 0.005 DBMET00193 0.041 0.014 DBMET00194 0.04 0.015 DBMET01311 | ||
| 0.086 | 0.034 | 0.155 | HIV-1 integrase inhibitor | 0.094 0.029 DBMET01729 0.094 0.029 DBMET00193 0.155 0.008 DBMET01312 | DBMET01312 | |
| 0.192 | 0.14 | 0.192 | 5 Hydroxytryptamine 1E antagonist | 0.187 0.146 DBMET01729 0.187 0.146 DBMET00193 | ||
| 0.101 | 0.049 | 0.131 | Phosphodiesterase 6D inhibitor | 0.103 0.047 DBMET01729 0.103 0.047 DBMET00193 0.129 0.018 DBMET00194 0.131 0.017 DBMET01311 | DBMET01311 | |
| 0.114 | 0.062 | 0.119 | 5 Hydroxytryptamine 3A agonist | 0.119 0.057 DBMET01729 0.119 0.057 DBMET00193 | DBMET00193 | |
| 0.062 | 0.011 | 0.062 | Nicotinic acid receptor agonist | 0.062 0.011 DBMET01729 0.062 0.011 DBMET00193 | ||
| 0.056 | 0.005 | 0.056 | Vanilloid 3 antagonist | 0.044 0.014 DBMET01729 0.044 0.014 DBMET00193 | ||
| 0.112 | 0.061 | 0.134 | Acetylcholine release stimulant | 0.105 0.076 DBMET01729 0.105 0.076 DBMET00193 0.115 0.056 DBMET00194 0.101 0.085 DBMET01311 0.134 0.03 DBMET01312 | DBMET01312 | |
| 0.065 | 0.014 | 0.065 | Adenylate cyclase 1 inhibitor | 0.062 0.017 DBMET01729 0.062 0.017 DBMET00193 | ||
| 0.063 | 0.012 | 0.066 | Dopamine beta hydroxylase inhibitor | 0.066 0.01 DBMET01729 0.066 0.01 DBMET00193 | DBMET00193 | |
| 0.074 | 0.023 | 0.074 | Corticotropin releasing factor 2 receptor antagonist | 0.071 0.027 DBMET01729 0.071 0.027 DBMET00193 | ||
| 0.064 | 0.014 | 0.065 | Oxytocin agonist | 0.065 0.013 DBMET01729 0.065 0.013 DBMET00193 | DBMET00193 | |
| 0.107 | 0.057 | 0.147 | Gastric antisecretory | 0.105 0.06 DBMET01729 0.105 0.06 DBMET00193 0.147 0.028 DBMET01312 | DBMET01312 | |
| 0.101 | 0.051 | 0.114 | Alcohol dehydrogenase inhibitor | 0.11 0.043 DBMET01729 0.11 0.043 DBMET00193 0.098 0.054 DBMET00194 0.114 0.039 DBMET01311 | DBMET01311 | |
| 0.104 | 0.054 | 0.104 | Nitric-oxide synthase inhibitor | 0.1 0.059 DBMET01729 0.1 0.059 DBMET00193 | ||
| 0.073 | 0.023 | 0.073 | NMDA 2A receptor antagonist | 0.066 0.026 DBMET01729 0.066 0.026 DBMET00193 | ||
| 0.055 | 0.005 | 0.059 | Cholesterol ester transfer protein antagonist | 0.054 0.005 DBMET01729 0.054 0.005 DBMET00193 0.059 0.005 DBMET01312 | DBMET01312 | |
| 0.053 | 0.003 | 0.078 | Thyroid hormone beta agonist | 0.078 0.002 DBMET01729 0.078 0.002 DBMET00193 | DBMET00193 | |
| 0.074 | 0.024 | 0.074 | Phosphodiesterase 1C inhibitor | 0.065 0.036 DBMET01729 0.065 0.036 DBMET00193 | ||
| 0.157 | 0.107 | 0.195 | P-glycoprotein inhibitor | 0.175 0.084 DBMET01729 0.175 0.084 DBMET00193 0.187 0.074 DBMET00194 0.195 0.067 DBMET01311 | DBMET01311 | |
| 0.061 | 0.011 | 0.061 | TRPM8 blocker | 0.046 0.018 DBMET01729 0.046 0.018 DBMET00193 | ||
| 0.137 | 0.088 | 0.342 | Insulin secretagoues | 0.157 0.067 DBMET01729 0.157 0.067 DBMET00193 0.339 0.009 DBMET00194 0.342 0.009 DBMET01311 | DBMET01311 | |
| 0.053 | 0.004 | 0.057 | Glutamate (mGluR3) agonist | 0.057 0.004 DBMET01729 0.057 0.004 DBMET00193 0.03 0.028 DBMET01311 | DBMET00193 | |
| 0.065 | 0.016 | 0.065 | Immunoglobulin Fc receptor antagonist | 0.059 0.027 DBMET01729 0.059 0.027 DBMET00193 | ||
| 0.051 | 0.003 | 0.052 | Estrogen-related receptor gamma antagonist | 0.052 0.003 DBMET01729 0.052 0.003 DBMET00193 0.032 0.013 DBMET01312 | DBMET00193 | |
| 0.062 | 0.015 | 0.062 | 5-Alpha-reductase inhibitor | 0.061 0.015 DBMET01729 0.061 0.015 DBMET00193 | ||
| 0.084 | 0.038 | 0.084 | Sphingosine 1-phosphate receptor antagonist | 0.083 0.039 DBMET01729 0.083 0.039 DBMET00193 | ||
| 0.082 | 0.036 | 0.082 | Toll-Like receptor 7 antagonist | 0.069 0.047 DBMET01729 0.069 0.047 DBMET00193 | ||
| 0.083 | 0.037 | 0.083 | Calcium channel L-type blocker | 0.072 0.049 DBMET01729 0.072 0.049 DBMET00193 | ||
| 0.053 | 0.007 | 0.056 | Liver X receptor beta antagonist | 0.056 0.006 DBMET01729 0.056 0.006 DBMET00193 | DBMET00193 | |
| 0.06 | 0.015 | 0.06 | Purinergic P2X4 antagonist | 0.057 0.017 DBMET01729 0.057 0.017 DBMET00193 | ||
| 0.049 | 0.004 | 0.049 | Retinoic acid alpha receptor antagonist | 0.045 0.004 DBMET01729 0.045 0.004 DBMET00193 | ||
| 0.049 | 0.005 | 0.049 | Calcium-sensing receptor antagonist | 0.036 0.005 DBMET01729 0.036 0.005 DBMET00193 | ||
| 0.048 | 0.004 | 0.048 | Imidazoline I1 receptor antagonist | 0.031 0.007 DBMET01729 0.031 0.007 DBMET00193 | ||
| 0.047 | 0.004 | 0.047 | Retinoid X gamma receptor antagonist | 0.045 0.004 DBMET01729 0.045 0.004 DBMET00193 0.03 0.012 DBMET00194 0.028 0.016 DBMET01311 0.029 0.014 DBMET01312 | ||
| 0.051 | 0.007 | 0.058 | ATP citrate lysase inhibitor | 0.058 0.005 DBMET01729 0.058 0.005 DBMET00193 | DBMET00193 | |
| 0.054 | 0.011 | 0.054 | Kainate receptor agonist | 0.049 0.015 DBMET01729 0.049 0.015 DBMET00193 | ||
| 0.046 | 0.004 | 0.046 | Retinoic acid receptor antagonist | 0.043 0.004 DBMET01729 0.043 0.004 DBMET00193 0.019 0.012 DBMET00194 0.019 0.013 DBMET01311 | ||
| 0.066 | 0.024 | 0.068 | 5 Hydroxytryptamine 7 agonist | 0.068 0.021 DBMET01729 0.068 0.021 DBMET00193 | DBMET00193 | |
| 0.071 | 0.029 | 0.074 | Transcription factor RelA inhibitor | 0.074 0.023 DBMET01729 0.074 0.023 DBMET00193 | DBMET00193 | |
| 0.054 | 0.013 | 0.054 | Farnesoid X receptor agonist | 0.048 0.016 DBMET01729 0.048 0.016 DBMET00193 0.051 0.014 DBMET01312 | ||
| 0.048 | 0.007 | 0.125 | Sodium/glucose cotransporter 2 inhibitor | 0.048 0.007 DBMET01729 0.048 0.007 DBMET00193 0.125 0.002 DBMET00194 0.123 0.002 DBMET01311 | DBMET00194 | |
| 0.065 | 0.024 | 0.065 | Dihydroorotate dehydrogenase inhibitor | 0.053 0.034 DBMET01729 0.053 0.034 DBMET00193 | ||
| 0.089 | 0.049 | 0.096 | Inducible nitric-oxide synthase inhibitor | 0.088 0.05 DBMET01729 0.088 0.05 DBMET00193 0.096 0.041 DBMET01312 | DBMET01312 | |
| 0.079 | 0.039 | 0.079 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.073 | 0.033 | 0.073 | Protease 3C (Human rhinovirus) inhibitor | 0.068 0.039 DBMET01729 0.068 0.039 DBMET00193 0.065 0.043 DBMET01312 | ||
| 0.063 | 0.023 | 0.063 | Leukotriene C antagonist | 0.061 0.028 DBMET01729 0.061 0.028 DBMET00193 | ||
| 0.055 | 0.016 | 0.066 | Guanylate cyclase inhibitor | 0.05 0.021 DBMET01729 0.05 0.021 DBMET00193 0.066 0.007 DBMET00194 0.058 0.013 DBMET01311 0.05 0.021 DBMET01312 | DBMET00194 | |
| 0.063 | 0.024 | 0.063 | Thromboxane synthase inhibitor | 0.058 0.03 DBMET01729 0.058 0.03 DBMET00193 | ||
| 0.062 | 0.024 | 0.147 | Alpha-mannosidase inhibitor | 0.06 0.027 DBMET01729 0.06 0.027 DBMET00193 0.147 0.004 DBMET00194 0.12 0.005 DBMET01311 0.075 0.014 DBMET01312 | DBMET00194 | |
| 0.066 | 0.028 | 0.066 | Thromboxane antagonist | 0.055 0.036 DBMET01729 0.055 0.036 DBMET00193 | ||
| 0.066 | 0.028 | 0.068 | Beta 2 adrenoreceptor agonist | 0.068 0.023 DBMET01729 0.068 0.023 DBMET00193 | DBMET00193 | |
| 0.119 | 0.082 | 0.122 | Antibacterial (Helicobacter pylori) | 0.122 0.079 DBMET01729 0.122 0.079 DBMET00193 0.115 0.089 DBMET01312 | DBMET00193 | |
| 0.063 | 0.026 | 0.063 | Thromboxane A2 antagonist | 0.052 0.034 DBMET01729 0.052 0.034 DBMET00193 | ||
| 0.069 | 0.032 | 0.069 | Alpha 2 adrenoreceptor agonist | 0.069 0.033 DBMET01729 0.069 0.033 DBMET00193 | ||
| 0.234 | 0.197 | 0.57 | Alpha-glucosidase inhibitor | 0.274 0.173 DBMET01729 0.274 0.173 DBMET00193 0.494 0.082 DBMET00194 0.57 0.061 DBMET01311 | DBMET01311 | |
| 0.077 | 0.041 | 0.077 | Potassium channel (Tandem pore domain) blocker | |||
| 0.061 | 0.025 | 0.072 | Glycine transporter 2 inhibitor | 0.072 0.02 DBMET01729 0.072 0.02 DBMET00193 | DBMET00193 | |
| 0.072 | 0.035 | 0.078 | Beta adrenoreceptor antagonist | 0.078 0.029 DBMET01729 0.078 0.029 DBMET00193 | DBMET00193 | |
| 0.057 | 0.021 | 0.074 | Estradiol 17 beta-dehydrogenase inhibitor | 0.074 0.014 DBMET01729 0.074 0.014 DBMET00193 | DBMET00193 | |
| 0.048 | 0.013 | 0.048 | Glutamate (mGluR8) agonist | 0.047 0.014 DBMET01729 0.047 0.014 DBMET00193 | ||
| 0.04 | 0.005 | 0.04 | Nicotinic acid receptor 2 antagonist | 0.038 0.005 DBMET01729 0.038 0.005 DBMET00193 | ||
| 0.07 | 0.034 | 0.075 | Aromatase inhibitor | 0.075 0.03 DBMET01729 0.075 0.03 DBMET00193 0.052 0.047 DBMET01312 | DBMET00193 | |
| 0.042 | 0.007 | 0.135 | Sodium/glucose cotransporter inhibitor | 0.041 0.007 DBMET01729 0.041 0.007 DBMET00193 0.135 0.002 DBMET00194 0.132 0.002 DBMET01311 | DBMET00194 | |
| 0.053 | 0.019 | 0.206 | Estrogen receptor beta agonist | 0.171 0.005 DBMET01729 0.171 0.005 DBMET00193 0.085 0.014 DBMET01311 0.206 0.004 DBMET01312 | DBMET01312 | |
| 0.038 | 0.003 | 0.038 | Retinoid X beta receptor antagonist | 0.032 0.004 DBMET01729 0.032 0.004 DBMET00193 | ||
| 0.099 | 0.065 | 0.121 | Bronchodilator | 0.121 0.044 DBMET01729 0.121 0.044 DBMET00193 | DBMET00193 | |
| 0.046 | 0.011 | 0.046 | Free fatty acid receptor 1 antagonist | 0.04 0.016 DBMET01729 0.04 0.016 DBMET00193 | ||
| 0.048 | 0.014 | 0.048 | Fumarate hydratase inhibitor | 0.045 0.016 DBMET01729 0.045 0.016 DBMET00193 0.036 0.022 DBMET00194 0.03 0.029 DBMET01311 | ||
| 0.081 | 0.047 | 0.081 | CYP2A6 inhibitor | 0.074 0.054 DBMET01729 0.074 0.054 DBMET00193 | ||
| 0.051 | 0.017 | 0.062 | Dihydrofolate reductase inhibitor | 0.052 0.017 DBMET01729 0.052 0.017 DBMET00193 0.062 0.009 DBMET01312 | DBMET01312 | |
| 0.097 | 0.063 | 0.097 | Sphingomyelinase inhibitor | 0.09 0.073 DBMET01729 0.09 0.073 DBMET00193 | ||
| 0.059 | 0.025 | 0.113 | Glucose-6-phosphate translocase inhibitor | 0.071 0.015 DBMET01729 0.071 0.015 DBMET00193 0.106 0.005 DBMET00194 0.113 0.005 DBMET01311 | DBMET01311 | |
| 0.037 | 0.005 | 0.037 | ICAM 1 antagonist | 0.035 0.005 DBMET01729 0.035 0.005 DBMET00193 | ||
| 0.043 | 0.011 | 0.043 | Leukotriene D4 antagonist | 0.041 0.012 DBMET01729 0.041 0.012 DBMET00193 | ||
| 0.036 | 0.005 | 0.069 | Vanilloid 2 agonist | 0.041 0.004 DBMET01729 0.041 0.004 DBMET00193 0.059 0.002 DBMET00194 0.069 0.002 DBMET01311 0.041 0.004 DBMET01312 | DBMET01311 | |
| 0.053 | 0.023 | 0.053 | NMDA receptor subunit 3B antagonist | 0.05 0.025 DBMET01729 0.05 0.025 DBMET00193 | ||
| 0.048 | 0.018 | 0.048 | Sphingosine kinase 1 inhibitor | 0.046 0.02 DBMET01729 0.046 0.02 DBMET00193 | ||
| 0.068 | 0.038 | 0.079 | NMDA receptor agonist | 0.057 0.051 DBMET01729 0.057 0.051 DBMET00193 0.079 0.029 DBMET01312 | DBMET01312 | |
| 0.047 | 0.018 | 0.047 | GABA uptake inhibitor | |||
| 0.043 | 0.014 | 0.045 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.045 0.013 DBMET01729 0.045 0.013 DBMET00193 | DBMET00193 | |
| 0.038 | 0.009 | 0.038 | CXC chemokine 2 receptor antagonist | 0.03 0.014 DBMET01729 0.03 0.014 DBMET00193 | ||
| 0.191 | 0.162 | 0.191 | Prostaglandin dehydrogenase inhibitor | 0.18 0.172 DBMET01729 0.18 0.172 DBMET00193 | ||
| 0.032 | 0.004 | 0.032 | Nicotinic acid receptor 1 antagonist | 0.032 0.004 DBMET01729 0.032 0.004 DBMET00193 | ||
| 0.056 | 0.028 | 0.061 | Beta 2 adrenoreceptor antagonist | 0.061 0.023 DBMET01729 0.061 0.023 DBMET00193 | DBMET00193 | |
| 0.055 | 0.027 | 0.055 | CD45 antagonist | 0.047 0.042 DBMET01729 0.047 0.042 DBMET00193 | ||
| 0.128 | 0.1 | 0.128 | Thiol protease inhibitor | |||
| 0.035 | 0.007 | 0.035 | Hedgehog signaling activator | 0.032 0.009 DBMET01729 0.032 0.009 DBMET00193 | ||
| 0.046 | 0.018 | 0.121 | Estrogen receptor alpha agonist | 0.121 0.006 DBMET01729 0.121 0.006 DBMET00193 0.03 0.026 DBMET01312 | DBMET00193 | |
| 0.044 | 0.017 | 0.044 | Glutamate (mGluR3) antagonist | 0.039 0.022 DBMET01729 0.039 0.022 DBMET00193 | ||
| 0.068 | 0.041 | 0.07 | Aryl hydrocarbon receptor antagonist | 0.07 0.037 DBMET01729 0.07 0.037 DBMET00193 | DBMET00193 | |
| 0.031 | 0.004 | 0.033 | Estrogen-related receptor gamma agonist | 0.033 0.004 DBMET01729 0.033 0.004 DBMET00193 | DBMET00193 | |
| 0.082 | 0.056 | 0.271 | Antineoplastic antibiotic | 0.099 0.047 DBMET01729 0.099 0.047 DBMET00193 0.257 0.013 DBMET00194 0.271 0.012 DBMET01311 0.1 0.046 DBMET01312 | DBMET01311 | |
| 0.07 | 0.045 | 0.071 | Alpha adrenoreceptor agonist | 0.071 0.045 DBMET01729 0.071 0.045 DBMET00193 | DBMET00193 | |
| 0.05 | 0.025 | 0.157 | Mannosidase inhibitor | 0.045 0.031 DBMET01729 0.045 0.031 DBMET00193 0.157 0.004 DBMET00194 0.117 0.005 DBMET01311 0.062 0.015 DBMET01312 | DBMET00194 | |
| 0.042 | 0.017 | 0.076 | Estrogen-related receptor alpha antagonist | 0.076 0.008 DBMET01729 0.076 0.008 DBMET00193 | DBMET00193 | |
| 0.045 | 0.02 | 0.045 | AMPA 4 receptor antagonist | 0.042 0.024 DBMET01729 0.042 0.024 DBMET00193 | ||
| 0.098 | 0.073 | 0.285 | AMP-activated protein kinase stimulant | 0.107 0.062 DBMET01729 0.107 0.062 DBMET00193 0.241 0.007 DBMET00194 0.285 0.005 DBMET01311 | DBMET01311 | |
| 0.056 | 0.032 | 0.068 | Leukotriene B4 antagonist | 0.055 0.035 DBMET01729 0.055 0.035 DBMET00193 0.065 0.023 DBMET00194 0.066 0.023 DBMET01311 0.068 0.021 DBMET01312 | DBMET01312 | |
| 0.062 | 0.038 | 0.062 | Plasminogen activator inhibitor | |||
| 0.039 | 0.016 | 0.039 | Liver X receptor beta agonist | 0.039 0.016 DBMET01729 0.039 0.016 DBMET00193 | ||
| 0.097 | 0.073 | 0.097 | Falcipain 3 inhibitor | |||
| 0.076 | 0.053 | 0.315 | Carbonic anhydrase XIII inhibitor | 0.096 0.04 DBMET01729 0.096 0.04 DBMET00193 0.112 0.033 DBMET00194 0.152 0.021 DBMET01311 0.315 0.005 DBMET01312 | DBMET01312 | |
| 0.05 | 0.027 | 0.05 | Purinergic P2Y antagonist | |||
| 0.028 | 0.005 | 0.028 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.024 0.008 DBMET01729 0.024 0.008 DBMET00193 | ||
| 0.048 | 0.025 | 0.048 | AICAR transformylase inhibitor | 0.045 0.029 DBMET01729 0.045 0.029 DBMET00193 0.04 0.037 DBMET01312 | ||
| 0.037 | 0.014 | 0.037 | Complement C5a chemotactic receptor antagonist | 0.03 0.02 DBMET01729 0.03 0.02 DBMET00193 | ||
| 0.047 | 0.025 | 0.047 | Glutamate (mGluR4) antagonist | |||
| 0.03 | 0.008 | 0.03 | Protease (Human cytomegalovirus) inhibitor | 0.023 0.014 DBMET01729 0.023 0.014 DBMET00193 | ||
| 0.047 | 0.025 | 0.047 | Glutamate (mGluR group III) antagonist | |||
| 0.052 | 0.031 | 0.052 | Peroxisome proliferator-activated receptor alpha agonist | 0.051 0.031 DBMET01729 0.051 0.031 DBMET00193 | ||
| 0.031 | 0.009 | 0.045 | Glutamate (mGluR1) agonist | 0.03 0.01 DBMET01729 0.03 0.01 DBMET00193 0.045 0.005 DBMET01312 | DBMET01312 | |
| 0.106 | 0.085 | 0.166 | M18 aspartyl aminopeptidase inhibitor | 0.166 0.045 DBMET01729 0.166 0.045 DBMET00193 | DBMET00193 | |
| 0.035 | 0.014 | 0.041 | Uridine phosphorylase inhibitor | 0.031 0.017 DBMET01729 0.031 0.017 DBMET00193 0.041 0.011 DBMET00194 0.03 0.018 DBMET01311 | DBMET00194 | |
| 0.055 | 0.035 | 0.055 | Ornithine carbamoyltransferase inhibitor | 0.051 0.039 DBMET01729 0.051 0.039 DBMET00193 | ||
| 0.042 | 0.021 | 0.042 | CF transmembrane conductance regulator antagonist | 0.039 0.029 DBMET01729 0.039 0.029 DBMET00193 | ||
| 0.086 | 0.066 | 0.086 | Phosphodiesterase I inhibitor | 0.081 0.074 DBMET01729 0.081 0.074 DBMET00193 | ||
| 0.143 | 0.123 | 0.183 | Psychostimulant | 0.148 0.118 DBMET01729 0.148 0.118 DBMET00193 0.179 0.093 DBMET00194 0.183 0.091 DBMET01311 | DBMET01311 | |
| 0.031 | 0.011 | 0.031 | Peroxisome proliferator-activated receptor alpha antagonist | 0.026 0.013 DBMET01729 0.026 0.013 DBMET00193 | ||
| 0.068 | 0.048 | 0.07 | Exportin-1 inhibitor | 0.07 0.043 DBMET01729 0.07 0.043 DBMET00193 | DBMET00193 | |
| 0.044 | 0.024 | 0.044 | Thymidine kinase inhibitor | 0.038 0.034 DBMET01729 0.038 0.034 DBMET00193 0.041 0.029 DBMET01312 | ||
| 0.023 | 0.004 | 0.023 | Imidazoline I2 receptor antagonist | 0.014 0.005 DBMET01729 0.014 0.005 DBMET00193 | ||
| 0.037 | 0.017 | 0.037 | Melatonin receptor 1A agonist | 0.034 0.021 DBMET01729 0.034 0.021 DBMET00193 | ||
| 0.041 | 0.022 | 0.041 | Leukotriene C4 antagonist | 0.039 0.027 DBMET01729 0.039 0.027 DBMET00193 | ||
| 0.031 | 0.012 | 0.031 | Prostaglandin H2 antagonist | 0.026 0.018 DBMET01729 0.026 0.018 DBMET00193 | ||
| 0.023 | 0.004 | 0.023 | Retinoic acid beta receptor antagonist | 0.02 0.004 DBMET01729 0.02 0.004 DBMET00193 | ||
| 0.124 | 0.106 | 0.442 | Hemostatic | 0.133 0.091 DBMET01729 0.133 0.091 DBMET00193 0.426 0.006 DBMET00194 0.442 0.005 DBMET01311 0.425 0.006 DBMET01312 | DBMET01311 | |
| 0.042 | 0.024 | 0.042 | NMDA receptor subunit 3A antagonist | 0.04 0.025 DBMET01729 0.04 0.025 DBMET00193 | ||
| 0.035 | 0.017 | 0.035 | Endothelial nitric-oxide synthase inhibitor | 0.029 0.024 DBMET01729 0.029 0.024 DBMET00193 | ||
| 0.045 | 0.027 | 0.045 | Histamine H2 receptor agonist | 0.04 0.035 DBMET01729 0.04 0.035 DBMET00193 | ||
| 0.056 | 0.039 | 0.063 | Beta 1 adrenoreceptor antagonist | 0.063 0.033 DBMET01729 0.063 0.033 DBMET00193 | DBMET00193 | |
| 0.024 | 0.007 | 0.024 | Alpha 2b adrenoreceptor agonist | 0.02 0.011 DBMET01729 0.02 0.011 DBMET00193 | ||
| 0.035 | 0.019 | 0.046 | Catechol O-methyltransferase inhibitor | 0.046 0.01 DBMET01729 0.046 0.01 DBMET00193 0.03 0.028 DBMET01312 | DBMET00193 | |
| 0.045 | 0.028 | 0.045 | Histamine H1 receptor agonist | |||
| 0.032 | 0.016 | 0.038 | Liver X receptor alpha antagonist | 0.038 0.01 DBMET01729 0.038 0.01 DBMET00193 | DBMET00193 | |
| 0.029 | 0.012 | 0.044 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.044 0.008 DBMET01729 0.044 0.008 DBMET00193 | DBMET00193 | |
| 0.022 | 0.006 | 0.032 | Telomerase stimulant | 0.022 0.006 DBMET01729 0.022 0.006 DBMET00193 0.031 0.003 DBMET00194 0.032 0.003 DBMET01311 | DBMET01311 | |
| 0.06 | 0.044 | 0.066 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.066 0.033 DBMET01729 0.066 0.033 DBMET00193 | DBMET00193 | |
| 0.054 | 0.038 | 0.06 | Ribonucleoside-diphosphate reductase inhibitor | 0.06 0.034 DBMET01729 0.06 0.034 DBMET00193 | DBMET00193 | |
| 0.049 | 0.034 | 0.056 | Topoisomerase II beta inhibitor | 0.056 0.025 DBMET01729 0.056 0.025 DBMET00193 0.053 0.029 DBMET01311 | DBMET00193 | |
| 0.024 | 0.009 | 0.026 | Neuraminidase (Influenza B) inhibitor | 0.026 0.007 DBMET01729 0.026 0.007 DBMET00193 | DBMET00193 | |
| 0.049 | 0.034 | 0.052 | Bombesin 2 receptor antagonist | 0.052 0.031 DBMET01729 0.052 0.031 DBMET00193 | DBMET00193 | |
| 0.056 | 0.041 | 0.063 | Fatty acid synthase inhibitor | 0.063 0.032 DBMET01729 0.063 0.032 DBMET00193 | DBMET00193 | |
| 0.058 | 0.043 | 0.058 | Carbonic anhydrase stimulant | 0.058 0.043 DBMET01729 0.058 0.043 DBMET00193 | ||
| 0.031 | 0.016 | 0.031 | Purinergic P2Y15 antagonist | 0.03 0.017 DBMET01729 0.03 0.017 DBMET00193 | ||
| 0.08 | 0.066 | 0.08 | Histamine N-methyltransferase inhibitor | |||
| 0.025 | 0.011 | 0.025 | Isoleucine-tRNA ligase inhibitor | 0.024 0.013 DBMET01729 0.024 0.013 DBMET00193 0.021 0.02 DBMET00194 | ||
| 0.022 | 0.008 | 0.038 | Antibiotic Anthracycline-like | 0.021 0.009 DBMET01729 0.021 0.009 DBMET00193 0.037 0.003 DBMET00194 0.038 0.003 DBMET01311 | DBMET01311 | |
| 0.054 | 0.04 | 0.061 | Ribonucleotide reductase inhibitor | 0.061 0.036 DBMET01729 0.061 0.036 DBMET00193 | DBMET00193 | |
| 0.03 | 0.016 | 0.03 | LFA antagonist | 0.025 0.024 DBMET01729 0.025 0.024 DBMET00193 | ||
| 0.021 | 0.008 | 0.064 | Ileal bile acid transport inhibitor | 0.021 0.008 DBMET01729 0.021 0.008 DBMET00193 0.064 0.003 DBMET00194 0.064 0.003 DBMET01311 | DBMET01311 | |
| 0.018 | 0.004 | 0.018 | Retinoic acid receptor gamma antagonist | 0.016 0.005 DBMET01729 0.016 0.005 DBMET00193 | ||
| 0.038 | 0.025 | 0.038 | Delayed rectifier potassium channel blocker | |||
| 0.038 | 0.025 | 0.038 | Histone deacetylase 7 inhibitor | |||
| 0.125 | 0.112 | 0.127 | Neuropeptide Y1 antagonist | 0.127 0.107 DBMET01729 0.127 0.107 DBMET00193 | DBMET00193 | |
| 0.025 | 0.012 | 0.049 | Glutamate (mGluR1a) agonist | 0.024 0.013 DBMET01729 0.024 0.013 DBMET00193 0.049 0.005 DBMET01312 | DBMET01312 | |
| 0.025 | 0.013 | 0.025 | Prostaglandin F2 alpha agonist | 0.025 0.013 DBMET01729 0.025 0.013 DBMET00193 | ||
| 0.033 | 0.021 | 0.044 | Estrogen-related receptor beta antagonist | 0.044 0.008 DBMET01729 0.044 0.008 DBMET00193 | DBMET00193 | |
| 0.051 | 0.04 | 0.051 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.028 | 0.017 | 0.028 | Lysine carboxypeptidase inhibitor | 0.028 0.018 DBMET01729 0.028 0.018 DBMET00193 | ||
| 0.052 | 0.041 | 0.176 | Heparanase inhibitor | 0.176 0.002 DBMET00194 0.138 0.003 DBMET01311 0.073 0.01 DBMET01312 | DBMET00194 | |
| 0.166 | 0.155 | 0.423 | Peptidyltransferase inhibitor | 0.182 0.126 DBMET01729 0.182 0.126 DBMET00193 0.421 0.005 DBMET00194 0.423 0.005 DBMET01311 | DBMET01311 | |
| 0.033 | 0.023 | 0.033 | Peroxisome proliferator-activated receptor delta agonist | 0.033 0.024 DBMET01729 0.033 0.024 DBMET00193 | ||
| 0.036 | 0.026 | 0.036 | Bombesin 1 receptor antagonist | 0.034 0.03 DBMET01729 0.034 0.03 DBMET00193 | ||
| 0.031 | 0.021 | 0.033 | Cyclophilin A inhibitor | 0.033 0.018 DBMET01729 0.033 0.018 DBMET00193 | DBMET00193 | |
| 0.031 | 0.021 | 0.037 | Liver X receptor antagonist | 0.037 0.016 DBMET01729 0.037 0.016 DBMET00193 | DBMET00193 | |
| 0.038 | 0.029 | 0.038 | Membrane dipeptidase inhibitor | 0.036 0.034 DBMET01729 0.036 0.034 DBMET00193 | ||
| 0.064 | 0.055 | 0.071 | Peroxisome proliferator-activated receptor gamma agonist | 0.071 0.048 DBMET01729 0.071 0.048 DBMET00193 | DBMET00193 | |
| 0.077 | 0.069 | 0.084 | NMDA receptor antagonist | 0.076 0.07 DBMET01729 0.076 0.07 DBMET00193 0.084 0.06 DBMET01312 | DBMET01312 | |
| 0.036 | 0.027 | 0.036 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.085 | 0.077 | 0.085 | MAP kinase kinase 1 inhibitor | |||
| 0.022 | 0.014 | 0.022 | Vitamin D receptor antagonist | 0.022 0.014 DBMET01729 0.022 0.014 DBMET00193 0.022 0.015 DBMET00194 0.022 0.016 DBMET01311 | ||
| 0.087 | 0.079 | 0.087 | Alpha 2c adrenoreceptor antagonist | |||
| 0.047 | 0.04 | 0.047 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.073 | 0.066 | 0.107 | Chymotrypsin inhibitor | 0.107 0.032 DBMET01312 | DBMET01312 | |
| 0.05 | 0.043 | 0.162 | Elastase inhibitor | 0.162 0.004 DBMET01312 | DBMET01312 | |
| 0.042 | 0.035 | 0.043 | Fructose-1,6-bisphosphatase inhibitor | 0.043 0.034 DBMET01729 0.043 0.034 DBMET00193 | DBMET00193 | |
| 0.03 | 0.024 | 0.03 | Glucocorticoid antagonist | 0.028 0.025 DBMET01729 0.028 0.025 DBMET00193 | ||
| 0.084 | 0.077 | 0.125 | Protein kinase C zeta inhibitor | 0.093 0.06 DBMET01729 0.093 0.06 DBMET00193 0.125 0.029 DBMET01312 | DBMET01312 | |
| 0.02 | 0.013 | 0.02 | 5-Alpha-reductase 2 inhibitor | 0.019 0.014 DBMET01729 0.019 0.014 DBMET00193 | ||
| 0.04 | 0.033 | 0.04 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.028 | 0.022 | 0.028 | Glucagon receptor antagonist | 0.027 0.024 DBMET01729 0.027 0.024 DBMET00193 | ||
| 0.02 | 0.013 | 0.02 | Caspase 8 inhibitor | 0.018 0.017 DBMET01729 0.018 0.017 DBMET00193 | ||
| 0.018 | 0.011 | 0.019 | Alpha 2a adrenoreceptor agonist | 0.019 0.01 DBMET01729 0.019 0.01 DBMET00193 | DBMET00193 | |
| 0.055 | 0.049 | 0.055 | Phosphodiesterase 1B inhibitor | |||
| 0.014 | 0.008 | 0.015 | Integrin alphaLbeta2 antagonist | 0.015 0.007 DBMET01729 0.015 0.007 DBMET00193 | DBMET00193 | |
| 0.09 | 0.085 | 0.09 | Alpha 2b adrenoreceptor antagonist | |||
| 0.056 | 0.051 | 0.056 | Phosphodiesterase 1A inhibitor | |||
| 0.056 | 0.051 | 0.056 | NMDA receptor glycine site agonist | |||
| 0.032 | 0.028 | 0.037 | Phosphoglycerate kinase inhibitor | 0.033 0.027 DBMET01729 0.033 0.027 DBMET00193 0.037 0.022 DBMET01312 | DBMET01312 | |
| 0.149 | 0.145 | 0.363 | Platelet antagonist | 0.363 0.035 DBMET00194 0.344 0.04 DBMET01311 0.192 0.107 DBMET01312 | DBMET00194 | |
| 0.013 | 0.009 | 0.013 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.018 | 0.014 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.015 DBMET01729 0.017 0.015 DBMET00193 | ||
| 0.132 | 0.128 | 0.471 | Platelet adhesion inhibitor | 0.154 0.101 DBMET01729 0.154 0.101 DBMET00193 0.465 0.007 DBMET00194 0.471 0.006 DBMET01311 0.443 0.008 DBMET01312 | DBMET01311 | |
| 0.046 | 0.042 | 0.058 | Cytokine production stimulant | 0.058 0.014 DBMET00194 0.05 0.029 DBMET01311 | DBMET00194 | |
| 0.013 | 0.009 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.051 | 0.048 | 0.051 | Epithelial sodium channel blocker | 0.051 0.048 DBMET01729 0.051 0.048 DBMET00193 | ||
| 0.043 | 0.04 | 0.045 | Beta adrenoreceptor agonist | 0.045 0.033 DBMET01729 0.045 0.033 DBMET00193 | DBMET00193 | |
| 0.076 | 0.074 | 0.08 | Myeloperoxidase inhibitor | 0.08 0.066 DBMET01729 0.08 0.066 DBMET00193 | DBMET00193 | |
| 0.016 | 0.013 | 0.016 | Vitamin D receptor agonist | 0.015 0.014 DBMET01729 0.015 0.014 DBMET00193 | ||
| 0.012 | 0.009 | 0.012 | Integrin beta2 antagonist | |||
| 0.01 | 0.008 | 0.01 | Thromboxane agonist | 0.01 0.009 DBMET01729 0.01 0.009 DBMET00193 | ||
| 0.035 | 0.034 | 0.036 | Dihydropteroate synthase inhibitor | 0.036 0.033 DBMET01729 0.036 0.033 DBMET00193 | DBMET00193 | |
| 0.014 | 0.013 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.012 DBMET01729 0.014 0.012 DBMET00193 | ||
| 0.029 | 0.028 | 0.031 | Calcitonin receptor agonist | 0.031 0.026 DBMET01729 0.031 0.026 DBMET00193 | DBMET00193 | |
| 0.011 | 0.01 | 0.012 | Glutamate (mGluR6) agonist | 0.012 0.009 DBMET01729 0.012 0.009 DBMET00193 | DBMET00193 | |
| 0.075 | 0.074 | 0.075 | Caspase 7 inhibitor | |||
| 0.03 | 0.029 | 0.068 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.068 0.009 DBMET01729 0.068 0.009 DBMET00193 | DBMET00193 | |
| 0.061 | 0.061 | 0.107 | NMDA 2 receptor antagonist | 0.107 0.029 DBMET01312 | DBMET01312 | |
| 0.046 | 0.046 | 0.07 | Alpha tubulin antagonist | 0.07 0.024 DBMET01729 0.07 0.024 DBMET00193 | DBMET00193 | |
| 0.02 | 0.021 | 0.047 | Dopamine D1 agonist | 0.026 0.011 DBMET01729 0.026 0.011 DBMET00193 0.025 0.013 DBMET00194 0.031 0.008 DBMET01311 0.047 0.005 DBMET01312 | DBMET01312 | |
| 0.057 | 0.058 | 0.061 | Histone deacetylase SIRT3 inhibitor | 0.061 0.046 DBMET01729 0.061 0.046 DBMET00193 | DBMET00193 | |
| 0.053 | 0.055 | 0.074 | Lipocortins synthesis agonist | 0.074 0.018 DBMET00194 0.072 0.019 DBMET01311 | DBMET00194 | |
| 0.019 | 0.022 | 0.022 | CYP24 inhibitor | 0.022 0.017 DBMET01729 0.022 0.017 DBMET00193 | DBMET00193 | |
| 0.062 | 0.065 | 0.072 | Protein kinase C beta inhibitor | 0.072 0.044 DBMET01729 0.072 0.044 DBMET00193 | DBMET00193 | |
| 0.043 | 0.046 | 0.123 | Aldose reductase inhibitor | 0.063 0.03 DBMET01729 0.063 0.03 DBMET00193 0.102 0.017 DBMET00194 0.123 0.014 DBMET01311 0.078 0.024 DBMET01312 | DBMET01311 | |
| 0.011 | 0.015 | 0.013 | Integrin alphaVbeta6 antagonist | 0.013 0.012 DBMET01729 0.013 0.012 DBMET00193 | DBMET00193 | |
| 0.093 | 0.098 | 0.098 | MAO inhibitor | 0.098 0.093 DBMET01729 0.098 0.093 DBMET00193 | DBMET00193 | |
| 0.012 | 0.018 | 0.014 | Integrin beta6 antagonist | 0.014 0.009 DBMET01729 0.014 0.009 DBMET00193 | DBMET00193 | |
| 0.104 | 0.111 | 0.167 | Interleukin 4 antagonist | 0.145 0.055 DBMET01729 0.145 0.055 DBMET00193 0.139 0.061 DBMET00194 0.167 0.036 DBMET01311 | DBMET01311 | |
| 0.044 | 0.052 | 0.124 | Carbonic anhydrase VB inhibitor | 0.053 0.042 DBMET01729 0.053 0.042 DBMET00193 0.124 0.012 DBMET01312 | DBMET01312 | |
| 0.08 | 0.09 | 0.295 | Topoisomerase I inhibitor | 0.129 0.05 DBMET01729 0.129 0.05 DBMET00193 0.263 0.015 DBMET00194 0.295 0.011 DBMET01311 | DBMET01311 | |
| 0.081 | 0.091 | 0.202 | Xanthine oxidase inhibitor | 0.095 0.064 DBMET01729 0.095 0.064 DBMET00193 0.154 0.033 DBMET00194 0.202 0.019 DBMET01311 | DBMET01311 | |
| 0.038 | 0.049 | 0.067 | Neuraminidase (Influenza A) inhibitor | 0.066 0.009 DBMET00194 0.067 0.009 DBMET01311 | DBMET01311 | |
| 0.027 | 0.039 | 0.077 | Purinergic P2Y2 antagonist | 0.077 0.005 DBMET01312 | DBMET01312 | |
| 0.088 | 0.101 | 0.101 | Protein kinase C gamma inhibitor | 0.101 0.075 DBMET01729 0.101 0.075 DBMET00193 | DBMET00193 | |
| 0.007 | 0.021 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.007 DBMET00194 0.01 0.009 DBMET01311 | DBMET00194 | |
| 0.102 | 0.12 | 0.19 | DNA repair enzyme inhibitor | 0.19 0.01 DBMET00194 0.185 0.012 DBMET01311 | DBMET00194 | |
| 0.022 | 0.041 | 0.064 | Arginase inhibitor | 0.061 0.01 DBMET00194 0.064 0.009 DBMET01311 | DBMET01311 | |
| 0.105 | 0.125 | 0.118 | Neurotrophic factor | 0.118 0.098 DBMET01729 0.118 0.098 DBMET00193 | DBMET00193 | |
| 0.051 | 0.078 | 0.155 | Carbonic anhydrase VA inhibitor | 0.155 0.01 DBMET01312 | DBMET01312 | |
| 0.042 | 0.07 | 0.051 | Vanilloid 2 antagonist | 0.051 0.038 DBMET01729 0.051 0.038 DBMET00193 | DBMET00193 | |
| 0.041 | 0.069 | 0.063 | Factor III inhibitor | 0.06 0.018 DBMET00194 0.063 0.015 DBMET01311 | DBMET01311 | |
| 0.034 | 0.064 | 0.069 | Carbonic anhydrase II inhibitor | 0.069 0.03 DBMET01312 | DBMET01312 | |
| 0.081 | 0.111 | 0.183 | Toll-Like receptor 4 antagonist | 0.094 0.08 DBMET01729 0.094 0.08 DBMET00193 0.179 0.01 DBMET00194 0.183 0.009 DBMET01311 | DBMET01311 | |
| 0.045 | 0.078 | 0.212 | Carbonic anhydrase V inhibitor | 0.212 0.006 DBMET01312 | DBMET01312 | |
| 0.054 | 0.086 | 0.236 | Topoisomerase II alpha inhibitor | 0.089 0.047 DBMET01729 0.089 0.047 DBMET00193 0.193 0.016 DBMET00194 0.236 0.011 DBMET01311 | DBMET01311 | |
| 0.095 | 0.129 | 0.121 | Histone deacetylase SIRT1 inhibitor | 0.121 0.089 DBMET01729 0.121 0.089 DBMET00193 | DBMET00193 | |
| 0.115 | 0.149 | 0.154 | CC chemokine 6 receptor antagonist | 0.154 0.018 DBMET00194 0.151 0.021 DBMET01311 | DBMET00194 | |
| 0.049 | 0.088 | 0.136 | Neuraminidase (influenza) inhibitor | 0.061 0.05 DBMET01729 0.061 0.05 DBMET00193 0.112 0.013 DBMET00194 0.13 0.01 DBMET01311 0.136 0.009 DBMET01312 | DBMET01312 | |
| 0.037 | 0.076 | 0.161 | Carbonic anhydrase inhibitor | 0.161 0.014 DBMET01312 | DBMET01312 | |
| 0.031 | 0.07 | 0.083 | Carbonic anhydrase XIV inhibitor | 0.059 0.025 DBMET00194 0.083 0.016 DBMET01311 | DBMET01311 | |
| 0.019 | 0.06 | 0.045 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.012 DBMET00194 0.033 0.008 DBMET01311 0.045 0.003 DBMET01312 | DBMET01312 | |
| 0.041 | 0.092 | 0.077 | Nitric oxide donor | 0.077 0.025 DBMET00194 0.076 0.026 DBMET01311 | DBMET00194 | |
| 0.003 | 0.056 | 0.017 | Antibiotic Macrolide-like | 0.017 0.008 DBMET00194 0.016 0.009 DBMET01311 | DBMET00194 | |
| 0.029 | 0.084 | 0.132 | Protein 50S ribosomal subunit inhibitor | 0.132 0.008 DBMET00194 0.126 0.009 DBMET01311 | DBMET00194 | |
| 0.028 | 0.083 | 0.055 | Beta tubulin antagonist | 0.055 0.043 DBMET01729 0.055 0.043 DBMET00193 | DBMET00193 | |
| 0.037 | 0.094 | 0.072 | Opioid mu receptor antagonist | 0.072 0.045 DBMET01729 0.072 0.045 DBMET00193 | DBMET00193 | |
| 0.076 | 0.136 | 0.123 | Tubulin antagonist | 0.123 0.077 DBMET01729 0.123 0.077 DBMET00193 | DBMET00193 | |
| 0.024 | 0.084 | 0.06 | Carbonic anhydrase I inhibitor | 0.06 0.035 DBMET01312 | DBMET01312 | |
| 0.032 | 0.094 | 0.107 | Neuraminidase inhibitor | 0.095 0.017 DBMET00194 0.107 0.013 DBMET01311 0.09 0.019 DBMET01312 | DBMET01311 | |
| 0.025 | 0.087 | 0.044 | Opioid mu receptor agonist | 0.044 0.035 DBMET01729 0.044 0.035 DBMET00193 | DBMET00193 | |
| 0.081 | 0.144 | 0.363 | Cell adhesion inhibitor | 0.363 0.006 DBMET00194 0.337 0.008 DBMET01311 | DBMET00194 | |
| 0.019 | 0.082 | 0.039 | Toll-Like receptor 4 agonist | 0.039 0.005 DBMET00194 0.037 0.006 DBMET01311 0.039 0.005 DBMET01312 | DBMET01312 | |
| 0.056 | 0.119 | 0.091 | Opioid antagonist | 0.091 0.056 DBMET01729 0.091 0.056 DBMET00193 | DBMET00193 | |
| 0.007 | 0.071 | 0.174 | Estrone sulfatase inhibitor | 0.174 0.003 DBMET01312 | DBMET01312 | |
| 0.127 | 0.191 | 0.465 | Tumour necrosis factor alpha release inhibitor | 0.172 0.133 DBMET01729 0.172 0.133 DBMET00193 0.454 0.019 DBMET00194 0.465 0.018 DBMET01311 | DBMET01311 | |
| 0.065 | 0.13 | 0.136 | Thioredoxin inhibitor | 0.127 0.026 DBMET00194 0.136 0.022 DBMET01311 | DBMET01311 | |
| 0.064 | 0.13 | 0.164 | DNA directed RNA polymerase inhibitor | 0.164 0.02 DBMET00194 0.163 0.02 DBMET01311 | DBMET00194 | |
| 0.028 | 0.098 | 0.062 | Opioid delta receptor antagonist | 0.062 0.045 DBMET01729 0.062 0.045 DBMET00193 | DBMET00193 | |
| 0.009 | 0.08 | 0.02 | Corticosteroid-like | 0.02 0.017 DBMET00194 0.02 0.018 DBMET01311 | DBMET01311 | |
| 0.054 | 0.128 | 0.214 | Cell adhesion molecule inhibitor | 0.214 0.009 DBMET00194 0.184 0.011 DBMET01311 | DBMET00194 | |
| 0.014 | 0.089 | 0.138 | NMDA 2D receptor antagonist | 0.138 0.003 DBMET01312 | DBMET01312 | |
| 0.026 | 0.102 | 0.054 | Microtubule stabilization | 0.054 0.023 DBMET00194 0.052 0.025 DBMET01311 | DBMET00194 | |
| 0.061 | 0.142 | 0.085 | Interleukin 5 antagonist | 0.083 0.067 DBMET00194 0.085 0.064 DBMET01311 | DBMET01311 | |
| 0.037 | 0.119 | 0.056 | Transcription factor AP-1 inhibitor | 0.056 0.053 DBMET01311 | DBMET01311 | |
| 0.019 | 0.105 | 0.064 | Phosphorylase inhibitor | 0.062 0.024 DBMET00194 0.064 0.023 DBMET01311 | DBMET01311 | |
| 0.03 | 0.119 | 0.127 | Factor IXa inhibitor | 0.107 0.008 DBMET00194 0.102 0.009 DBMET01311 0.127 0.005 DBMET01312 | DBMET01312 | |
| 0.031 | 0.125 | 0.068 | HIV-1 reverse transcriptase inhibitor | 0.068 0.051 DBMET01312 | DBMET01312 | |
| 0.007 | 0.102 | 0.043 | Squalene synthetase inhibitor | 0.043 0.017 DBMET00194 0.037 0.019 DBMET01311 | DBMET00194 | |
| 0.053 | 0.157 | 0.133 | Breast cancer-resistant protein inhibitor | 0.133 0.031 DBMET01312 | DBMET01312 | |
| 0.051 | 0.167 | 0.309 | Topoisomerase II inhibitor | 0.098 0.088 DBMET01729 0.098 0.088 DBMET00193 0.262 0.023 DBMET00194 0.309 0.017 DBMET01311 | DBMET01311 | |
| 0.023 | 0.15 | 0.39 | Selectin antagonist | 0.39 0.003 DBMET00194 0.386 0.003 DBMET01311 0.267 0.007 DBMET01312 | DBMET00194 | |
| 0.011 | 0.139 | 0.077 | Factor Xa inhibitor | 0.077 0.019 DBMET01312 | DBMET01312 | |
| 0.01 | 0.144 | 0.064 | Protein 30S ribosomal subunit inhibitor | 0.064 0.005 DBMET00194 0.064 0.005 DBMET01311 | DBMET01311 | |
| 0.062 | 0.197 | 0.357 | Thrombolytic | 0.357 0.016 DBMET00194 0.357 0.016 DBMET01311 0.226 0.041 DBMET01312 | DBMET01311 | |
| 0.021 | 0.182 | 0.061 | H+/K+-transporting ATPase inhibitor | 0.061 0.024 DBMET01312 | DBMET01312 | |
| 0.017 | 0.211 | 0.085 | Antibiotic Aminoglycoside-like | 0.085 0.004 DBMET00194 0.083 0.004 DBMET01311 | DBMET00194 | |
| 0.048 | 0.254 | 0.152 | Transcription factor NF kappa B stimulant | 0.152 0.015 DBMET00194 0.149 0.016 DBMET01311 | DBMET00194 | |
| 0.034 | 0.248 | 0.134 | DNA intercalator | 0.13 0.052 DBMET00194 0.134 0.05 DBMET01311 | DBMET01311 | |
| 0.014 | 0.261 | 0.968 | Cholecystokinin B agonist | 0.968 0.001 DBMET01312 | DBMET01312 | |
| 0.05 | 0.316 | 0.09 | T cell inhibitor | 0.09 0.037 DBMET00194 0.082 0.057 DBMET01311 | DBMET00194 | |
| 0.005 | 0.289 | 0.069 | Dopamine D2 agonist | 0.069 0.017 DBMET01312 | DBMET01312 | |
| 0.023 | 0.322 | 0.113 | Histone deacetylase stimulant | 0.092 0.033 DBMET00194 0.113 0.021 DBMET01311 | DBMET01311 | |
| 0.023 | 0.322 | 0.113 | Histone deacetylase SIRT1 stimulant | 0.092 0.033 DBMET00194 0.113 0.021 DBMET01311 | DBMET01311 | |
| 0.089 | 0.394 | 0.446 | Immunomodulator | 0.446 0.032 DBMET00194 0.421 0.038 DBMET01311 | DBMET00194 | |
| 0.042 | 0.348 | 0.405 | Dual specificity phosphatase 3 inhibitor | 0.405 0.013 DBMET01312 | DBMET01312 | |
| 0.042 | 0.36 | 0.41 | Dual specificity phosphatase inhibitor | 0.41 0.013 DBMET01312 | DBMET01312 | |
| 0.005 | 0.342 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.014 DBMET00194 | DBMET00194 | |
| 0.009 | 0.369 | 0.319 | NMDA 2B receptor antagonist | 0.319 0.004 DBMET01312 | DBMET01312 | |
| 0.004 | 0.418 | 0.502 | Cholecystokinin antagonist | 0.502 0.003 DBMET01312 | DBMET01312 | |
| 0.003 | 0.455 | 0.487 | Cholecystokinin B antagonist | 0.487 0.003 DBMET01312 | DBMET01312 | |
| 0.004 | 0.475 | 0.576 | Cholecystokinin A antagonist | 0.576 0.003 DBMET01312 | DBMET01312 | |
| 0.004 | 0.49 | 0.853 | Cholecystokinin A agonist | 0.853 0.001 DBMET01312 | DBMET01312 | |
| 0.003 | 0.501 | 0.869 | Cholecystokinin agonist | 0.869 0.001 DBMET01312 | DBMET01312 | |
| 0.019 | 0.527 | 0.26 | Multidrug resistance-associated protein 1 inhibitor | 0.117 0.052 DBMET00194 0.123 0.045 DBMET01311 0.26 0.005 DBMET01312 | DBMET01312 | |
| 0.012 | 0.522 | 0.115 | Thrombin inhibitor | 0.115 0.019 DBMET01312 | DBMET01312 | |
| 0.004 | 0.523 | 0.021 | Motilin receptor agonist | 0.021 0.02 DBMET00194 | DBMET00194 | |
| 0.019 | 0.551 | 0.569 | Anticoagulant | 0.24 0.041 DBMET00194 0.229 0.044 DBMET01311 0.569 0.007 DBMET01312 | DBMET01312 | |
| 0.031 | 0.609 | 0.372 | Angiogenesis inhibitor | 0.372 0.062 DBMET01312 | DBMET01312 | |
| 0.003 | 0.673 | 0.036 | Factor XI inhibitor | 0.036 0.02 DBMET01312 | DBMET01312 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |